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Abstract
Background. Transgender and non-binary (TGNB) populations experience disproportionally
high levels of anxiety and depression; it is imperative we investigate how the COVID-19
pandemic may have impacted the mental health of TGNB communities.
Methods. Among a Canadian sample of TGNB persons aged 15 years, we used multiple
linear regression to examine whether interruptions in gender-affirming care were associated
with anxiety and depression, and whether that effect was modified by pre-pandemic mental
health.

Results. Anxiety and depression levels were high both pre-pandemic and during the
pandemic. Approximately a quarter of TGNB persons experienced interruptions in hormonal
care. After adjusting for confounders, there was no association between interruptions in
gender-affirming care and anxiety. However, interruptions in hormonal care was associated
with increased depressive symptoms during the pandemic, and this effect was modified by
pre-pandemic depression.

Conclusion. Interruptions in hormonal care may have increased depressive symptoms in an
already highly-depressed group of TGNB persons.
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Coronavirus, COVID-19, transgender, non-binary, mental health, gender-affirming medical
care, anxiety, depression, Canada, longitudinal
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Summary for Lay Audience
The World Health Organization (WHO) declared the coronavirus disease (COVID-19) a
global health pandemic on March 11th, 2020. Since then, there have been major social, health
and economic changes. The shut down of “non-essential” businesses contributed to increased
unemployment rates, school closures forced students and teachers to adapt to a virtual
learning environment, and disruptions in health-care systems resulted in an increase in unmet
health care needs. Evidently, the COVID-19 pandemic has resulted in an increasing number
of disruptions to daily life for individuals globally. This has raised concerns about whether
these changes have contributed to increased mental health challenges; especially for
marginalized populations, such as the transgender and non-binary (TGNB) community.
Given that TGNB Canadians have previously experienced inequities in health care access
and socioeconomic disadvantages, COVID-19-related disruptions may disproportionally
affect this population.
Gender dysphoria is the feeling of distress that some TGNB persons experience due to their
gender identity differing from their sex assigned at birth. Gender-affirming care is a medical
intervention that can help alleviate this distress. This type of healthcare is available in
Canada and it includes treatments such as, puberty blockers, hormone therapy and surgeries.
Importantly, there have been documented benefits and improvements in mental health,
including anxiety and depression, after receiving gender-affirming care.
This thesis used data from Trans PULSE Canada; a study that collected data on the health
and well-being of Canadian TGNB persons aged 14 years pre-pandemic (2019) and one
year later, during the pandemic (2020). In this study, we found that TGNB persons were
experiencing high levels of anxiety and depression symptoms both pre-pandemic and during
the pandemic. Pandemic anxiety severity was not different from pre-pandemic levels;
however, depression symptoms during the pandemic were higher compared to pre-pandemic.
We also found that interruptions in gender-affirming care was not linked to anxiety levels
during the pandemic. In contrast, interruptions in gender-affirming care, specifically
interruptions in hormonal care, played a role in increased depression during the pandemic,
wherein interruptions in hormonal care played a greater role on pandemic depression for
those who were less depressed pre-pandemic.
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Chapter 1

1

Introduction

This chapter will explain the rationale and study objectives for this thesis.

1.1 Overview of study rationale
The World Health Organization (WHO) declared the coronavirus disease (COVID-19) a
global health pandemic on March 11th, 2020 (WHO, 2020b). Within a short period of
time, COVID-19 has had detrimental health effects on millions of individuals, notably
among older adults and those with pre-existing medical conditions. As morbidity and
mortality rates continue to be monitored globally, broader impacts of COVID-19 have
also been recognized, such as disruptions in healthcare systems, social gatherings and
events, and economic strain (Haleem et al., 2020). At the beginning of the pandemic,
many countries opted to shut down “non-essential” businesses; consequently,
unemployment rates increased significantly. In Canada alone, the economic shutdown
resulted in the unemployment rate increasing more than two-fold from 5.6% in February
to 13.7% in May of 2020 (Statistics Canada, 2020a). School closures forced students to
learn from home via an online format, and stay-at-home orders along with social
gathering limits were implemented to slow down the spread of the virus, resulting in
individuals social distancing from peers and even close family members. Moreover, due
to the potential influx of COVID-19 patients in hospitals and scarce medical resource
availability, non-urgent medical care were put on hold or delayed for many individuals,
resulting in an increase in unmet health care needs (Canadian Agency for Drugs and
Technologies in Health, 2020). These additional, indirect burdens of the COVID-19
disease have affected the lives of individuals in other ways, alongside physical health
(Dubey et al., 2020).
As SARS-CoV-2 is a novel viral strand that has not been previously identified (WHO,
2020b), it has resulted in an abundance of research being conducted on the development
of a treatment for infected patients, in addition with how to best advise the public on
strategies to prevent the spread of infection (Banerjee & Nair, 2020; Sirotich &
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Hausmann, 2021). Given the race to vaccinate populations and the focus on mitigating
the spread of the virus, there has been limited research efforts on how the COVID-19
pandemic has impacted minority populations. In particular, sexual and gender minority
populations (SGM) are underrepresented (Phillips et al., 2020; Sirotich & Hausmann,
2021). The impact of the virus itself is largely unknown among the transgender and nonbinary (TGNB) population due to the lack of inclusion of sexual orientation and gender
identity in surveillance data (Phillips et al., 2020). Efforts to mitigate the impacts of
COVID-19, including health care interruptions and socioeconomic disruptions are being
experienced across Canada (Chen-See, 2020; Statistics Canada, 2020b). However, these
disruptions may be particularly severe for TGNB Canadians given pre-existing inequities
in health care access and socioeconomic disadvantages (Bauer & Scheim, 2015). In the
U.S., it was reported that 13.1% of the lesbian, gay, bisexual and transgender (LGBT)
adult population experienced food insecurity due to the pandemic, compared to 7.2% of
adults who were not LGBT (File & Marshall, 2021). The U.S. Census Bureau Survey
data also revealed that LGBT persons experienced greater economic struggles than their
non-LGBT counterparts. Therefore, there is evidence to suggest that inequities are being
further magnified by the COVID-19 pandemic.
There has also been an increase in unmet health care needs due to the delay in non-urgent
medical care. These delays have also affected TGNB persons due to the postponement of
in-person consultation and surgeries. As a result, there may be an increased difficulty
accessing hormone therapy and/or gender-affirming surgeries during the pandemic
(Wang et al., 2020). Even prior to the pandemic, many TGNB persons seeking genderaffirming medical care have had to overcome obstacles to schedule their appointments
and surgical procedures, including financial, legal and geographic barriers (Roberts et al.,
2020). The usual wait times that are experienced can be even further exacerbated due to
the pandemic. Moreover, previous research has demonstrated that TGNB communities
already experience increased health and mental health concerns compared to the general
and lesbian, gay, and bisexual (LGB) populations (Grant et al., 2011; Su et al., 2016),
which becomes increasingly concerning with the impacts of COVID-19. Given that
gender-affirming care has repeatedly demonstrated improvements in mental health
outcomes in TGNB persons (Baker et al., 2021; Passos et al., 2020; Wernick et al., 2019;
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White Hughto & Reisner, 2016), it is imperative we investigate whether difficulties in
accessing gender-affirming care during the pandemic have impacted the mental health of
this population.
In general, there is limited research on the effects of delays to gender-affirming care due
to COVID-19 on TGNB peoples’ mental health. The majority of the current literature
consists of perspectives, commentaries and opinion pieces on sex and gender equity
issues, with few primary and secondary studies that have investigated the effects of the
COVID-19 pandemic on TGNB peoples’ mental health. In Canada, no major health
survey has captured the experiences of lesbian, gay, bisexual, transgender, queer (or
sometimes questioning), and two-spirited (LGBTQ2+) Canadians during the pandemic
(Prokopenko & Kevins, 2020). Therefore, it is evident that there is a gap in the current
literature on the impact of pandemic-related delays in gender-affirming care on TGNB
mental health in Canada. Fortunately, the Trans PULSE Canada study is a communitybased survey that has collected data on TGNB health and well-being both pre-pandemic
and during the pandemic. This provides a unique opportunity to conduct a longitudinal
study that can fill the current gap in literature and shed light on some of the impacts that
the COVID-19 pandemic has had on TGNB individuals in Canada.

1.2 Thesis objectives
The purpose of this thesis is to determine the impact of interruptions in gender-affirming
medical care during COVID-19 on anxiety and depression levels among TGNB persons
in Canada. The following objectives will be addressed:

1. Identify the characteristics of TGNB persons in Canada at the time of the
COVID-19 pandemic, as well as the characteristics of TGNB individuals
experiencing interruptions in gender-affirming medical care during the pandemic.

2. Describe interruptions in gender-affirming medical care during the COVID-19
pandemic in Canada.
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3. Identify if there are differences in anxiety and depression levels among TGNB
individuals from pre-pandemic to pandemic periods.

4. Examine if there is a relationship between interruptions in gender-affirming
medical care and pandemic anxiety levels.

a. Model 1— interruptions in gender-affirming medical care as a predictor of
pandemic anxiety, adjusting for pre-pandemic anxiety.

b. Model 2— interruptions in gender-affirming medical care as a predictor of
pandemic anxiety, assessing for an interaction between interruptions in
care and pre-pandemic anxiety levels and adjusting for other potential
confounders.

c. Model 3— interruptions in gender-affirming medical care as a predictor of
pandemic anxiety, adjusting for pre-pandemic anxiety and other potential
confounders.

5. Examine if there is a relationship between interruptions in gender-affirming
medical care and pandemic depression levels.

a. Model 1— interruptions in gender-affirming medical care as a predictor of
pandemic depression, adjusting for pre-pandemic depression.

b. Model 2— interruptions in gender-affirming medical care as a predictor
of pandemic depression, assessing for an interaction between interruptions
in care and pre-pandemic depression levels and adjusting for other
potential confounders.
c. Model 3— interruptions in gender-affirming medical care as a predictor of
pandemic depression, adjusting for pre-pandemic depression and other
potential confounders.
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Chapter 2

2

Literature Review

The following chapter will provide an overview of TGNB mental health pre-pandemic
and the role of gender affirmation (social, legal and medical) in mental health with a
specific focus on gender-affirming medical care. It will also briefly review the literature
that is available on the global impact of COVID-19 and how changes related to the
pandemic may play a role in the lives of TGNB people. Finally, this review will discuss
the current available research on TGNB mental health during the COVID-19 pandemic,
as well as the implications of interruptions in gender-affirming medical care on TGNB
mental health.

2.1 TGNB mental health pre-pandemic
Sex assigned at birth is the assignment of male or female to an infant based on the
appearance of the genitalia at birth. Gender differs from biological sex in the sense that it
is used to describe the socially constructed and accepted roles, behaviours, expressions
and identities of individuals, which can change over time (Canadian Institutes of Health
Research, 2020). One’s gender identity may be the same or different from their sex
assigned at birth. Cisgender denotes persons whose gender identity is congruent with
their biological sex. In contrast, transgender is an umbrella term used to describe
individuals whose gender identity does not align with their sex assigned at birth (GLAAD
Media Reference Guide, 2016). This includes persons who identify as women, men, nonbinary, genderqueer, cross-dresser, transexual, along with other gender identities.
Individuals whose gender identity does not simply fit into the two categories, man or
woman, may identify themselves as non-binary or genderqueer (GLAAD Media
Reference Guide, 2016).
Prior to the onset of the current pandemic, TGNB adults and adolescents were already
experiencing disproportionally high levels of anxiety, depression, and suicidal thoughts
(Becerra-Culqui et al., 2018; Kattari et al., 2020). Multiple studies have reported
depression prevalence rates ranging from 50% to 67% (Clements-Nolle et al., 2006; Kim
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et al., 2006; Nuttbrock et al., 2010). In comparison, in the Canadian general population,
the prevalence of depression is 4.7% (Pearson et al., 2013). This highlights the
importance of attending to the mental health needs of this population. Canadian studies
using clinical samples have reported that TGNB persons may be experiencing high levels
of anxiety and depression. A recent retrospective chart review of TGNB persons referred
to a transgender clinic in Kingston, Ontario reported that almost two thirds of the clinical
sample was diagnosed with an anxiety disorder in their lifetime and just over half of the
sample was diagnosed with mood disorders (She et al., 2020). Another Canadian clinical
study of TGNB youth in Vancouver reported that 24% and 35% of their sample had an
anxiety disorder and mood disorder, respectively (Khatchadourian et al., 2014).
Other countries, such as the U.K. and U.S, have also reported a high prevalence of
anxiety, depression, suicide and self-harm in clinical samples of TGNB persons. A U.S.
retrospective cohort study that used electronic medical records of transgender youth
matched with cisgender counterparts revealed mental health disparities between the two
populations (Reisner et al., 2015). This study revealed that transgender youth had a
greater risk of being diagnosed with anxiety (RR: 3.27; 95% CI: 1.80, 5.95) and
depression (RR: 3.95; 95% CI: 2.60, 5.99), compared to their matched cisgender peers. A
study in the UK investigated levels of depression among a large clinical sample of TGNB
persons who had been referred to a national transgender health service (Witcomb et al.,
2018). Among TGNB persons who were not currently on hormone therapy, the risk of a
possible depressive disorder or probable depressive disorder was four times higher in
TGNB persons compared to the general UK population (Witcomb et al., 2018). However,
it is important to note that clinical samples might not provide the most accurate
representation of mental health for TGNB persons in the community. Clinical samples
might overrepresent the proportion of TGNB persons experiencing mental health
challenges since mental health or inability to cope would likely lead these individuals to
make the decision to clinically address their gender dysphoria.
Heightened mental health challenges have also been reported in non-clinical samples of
TGNB Canadians. The Trans PULSE Project, a community-based research project,
reported that approximately 61.2% of transfeminine individuals experienced symptoms
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that could be classified as having clinical depression (Rotondi, Bauer, Travers, et al.,
2011). The Trans PULSE Project also reported that the prevalence of depression was
similar for transmasculine individuals, with about two-thirds reporting symptoms that are
consistent with a clinical depression diagnosis (Rotondi, Bauer, Scanlon, et al., 2011).
Moreover, rates of suicidal ideation and attempts were high in transgender Ontarians
where 35.1% reported suicidal ideation and 11.2% attempted suicide in the past year
(Bauer et al., 2015). Similarly, the Canadian Trans Youth Health Survey revealed a
heightened prevalence of mental health challenges in youth and young adults across
Canada (Veale, Peter, Travers, et al., 2017). Among TGNB youth aged 14-18, almost
75% reported non-suicidal self-injury in the past year, about 35% reported a suicide
attempt in the past year and 45% reported extreme stress. Among TGNB young adults
aged 19-25, over half of the respondents reported non-suicidal self-injury in the past year,
close to 75% reported having ever seriously considered suicide and 71% reported feeling
depressed in the past year (Veale, Peter, Travers, et al., 2017). One Canadian study noted
significant mental health disparities when comparing the mental health of TGNB persons
to the general population in Canada that were matched on age. Among those aged 19 to
25 years, greater psychological distress was reported for TGNB individuals when
compared to a general population of young adults from the Canadian Community Health
Survey (Veale, Watson, Peter, et al., 2017). Moreover, compared to the general
population of youth, there was also a significantly greater proportion of TGNB
individuals who reported a major depressive episode in the past year (71.1% vs. 7.8%),
suicidal ideation in their lifetime (74.4% vs 15.4%), and suicide attempts in their lifetime
(37.8% vs. 3.4%). When comparing gender identities, self-harm was reported more often
in non-binary and transmasculine individuals, with non-binary persons reporting worse
levels of mental health overall (Veale, Watson, Peter, et al., 2017). Suicide and self-harm
may be fatal and/or harmful consequences of anxiety and depression in the TGNB
community. As previously discussed, the prevalence of depression is much higher in the
TGNB population compared to the general population in Canada. The same trend seems
to follow for anxiety disorders. Jaffray (2020) reported that Canadian TGNB persons
were more likely to be diagnosed with an anxiety disorder than Canadian cisgender
persons (57.0% vs. 13.1%). This demonstrates that TGNB persons in Canada are likely
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experiencing a disproportionally high level of pre-pandemic mental health challenges
compared to other Canadian populations.
Several community-based studies in other countries have also found similar mental health
trends in their TGNB communities. An online survey that was conducted in Australia and
New Zealand investigated the health and well-being of TGNB communities (Pitts et al.,
2009). The study revealed that 36.2% of TGNB persons had depressive symptoms that
were indicative of a current major depressive disorder. The prevalence of depression
found in this sample of TGNB individuals was also much higher relative to the general
Australian population where 6.2% of Australians experienced an affective disorder in a
12-month period (Australian Bureau of Statistics, 2007). Another study used a national
community sample to investigate the mental health and well-being of TGNB youth aged
14 to 25 across Australia (Smith et al., 2014). This study reported that 45% and 47% of
the participants reported an anxiety and depression diagnosis, respectively. A
community-based study with TGNB participants from the UK and Ireland reported
similar mental health challenges (McNeil et al., 2012). This study revealed that 63% of
their sample had suicidal ideation in the past year and 11% had attempted suicide in the
past year. Anxiety and depression levels were also concerning with 55% and 38%
reporting having had/currently having a depression and anxiety diagnosis, respectively
(McNeil et al., 2012). The 2015 U.S. Transgender Survey reported that 39% of TGNB
persons experienced psychological distress compared to 5% of the general U.S.
population (James et al., 2016). Therefore, a heightened prevalence of mental health
challenges has been noted in TGNB populations with significant differences relative to
the general population. This raises concerns about whether the COVID-19 pandemic is
further exacerbating anxiety and depressive symptomology in TGNB individuals

2.2 Gender affirmation and its role in mental health: social,
legal and medical
Gender affirmation is the social acceptance and recognition of an individuals’ gender
identity, role, and/or expression (Sevelius, 2013). A TGNB person’s transition may have
social, legal and/or medical aspects in which some or all can contribute to an individuals’
gender affirming process. Social gender affirmation might include things like “coming
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out”, the correct use of preferred names and pronouns, social support from friends, family
and/or strangers, and dressing in clothing that expresses one’s gender identity (Glynn et
al., 2016). Previous research has shown that social gender affirmation has an impact on
the health and well-being of TGNB persons. A U.S. study examined the association
between gender affirmation and psychological well-being and determined that
transgender women with family support had lower levels of depression and higher selfesteem (Glynn et al., 2016). These findings remain consistent among other studies where
there have been positive mental health outcomes and lower levels of anxiety and
depression found in transgender persons who have social support (Ryan et al., 2010;
Murdock & Bolch, 2005). In contrast, TGNB individuals who were experiencing high
levels of family rejection exhibited more depressive symptoms, suicidal ideation and
attempts, and substance misuse (Yadegarfard et al., 2014; Klein & Golub, 2016).
Furthermore, the use of preferred names and pronouns can have many positive
implications on TGNB mental health. A U.S. study of 129 transgender and gender
diverse youth reported that those who had the ability to use their preferred names had
lower levels of depression and suicidal behaviours (Russell et al., 2018). Using correct
preferred names and pronouns allows TGNB persons to feel supported in their felt gender
while also decreasing stress levels; ultimately resulting in better mental health outcomes
(Brown et al., 2020).
Legal gender affirmation refers to making changes to legal documentation (e.g., birth
certificate, passport, driver’s license) to reflect an individual’s current gender identity.
Some TGNB persons continue to face difficulties when seeking legal documentation
changes. For example, in the U.S., some states require medical documentation from a
doctor/psychiatrist as well a history of gender-affirming medical care (e.g., use of
hormones and/or surgery) to receive approval for a name change (Restar et al., 2020). In
Ontario, when requesting a change in sex designation on birth certificates, medical
documentation from a physician or psychologist is required to support the application
(Service Ontario, 2021). However, gender-affirming surgeries are not required to apply
for gender marker or name changes on legal documents across Canada. This
demonstrates that countries and/or regions may have different existing policies when it
comes to legal gender affirmation.
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It is important for TGNB persons to have access to gender congruent identity documents
as it may impede their daily lives in multiple aspects, including their ability to travel,
seek employment opportunities, and access social and healthcare services (Malta et al.,
2020). If access is restricted, it may result in TGNB individuals living in social isolation
or even avoiding necessary medical care, which could ultimately result in basic human
rights being unintentionally revoked from this already marginalized population.
Moreover, previous literature has demonstrated that legal gender affirmation has
significant implications on mental health among TGNB individuals. A Canadian
community-based research study revealed that among transgender Ontarians aged 16 and
over, having at least one identity document corresponding to current gender identity was
associated with a reduction in past year suicide ideation and attempts (Bauer et al., 2015).
A recent study based in the U.S. also revealed that compared to those who did not
undergo legal gender marker and name changes, those who did reported lower levels of
depression, anxiety and psychiatric distress (Restar et al., 2020). Similarly, a crosssectional study conducted in the U.S. reported that compared to those who did not have
ID’s congruent with their gender, psychological distress and suicidal ideation and
planning was lower among those who did have all their ID’s congruent with their gender
(Scheim et al., 2020). This demonstrates that legal gender affirmation may play a
significant role in TGNB mental health and further emphasizes the importance for policy
makers to reduce barriers and ease access to legal document changes for TGNB persons.
Some TGNB persons may experience distress and/or discomfort due to the discordance
between their gender identity and sex assigned at birth—this is known as gender
dysphoria (American Psychiatric Association, 2013). Studies have suggested that both
adolescent and adults experiencing gender dysphoria are increasingly seeking support and
care at gender identity clinics in both Europe and North America (de Vries et al., 2015;
Aitken et al., 2015). Fortunately, treatments are available to TGNB persons who are
experiencing discomfort or distress.
Gender-affirming medical care is one such treatment that may alleviate symptoms
through aligning one’s gender identity with their physical appearance. This can be
attained through using puberty blockers, hormone therapy, and/or surgery. Puberty
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blockers are sometimes prescribed for adolescents who are experiencing gender
dysphoria in order to suppress the production of estrogen and testosterone, and ultimately
delay changes to the body that occur during the pubescent years (World Professional
Association for Transgender Health [WPATH], 2012). Research has demonstrated that
the effects of puberty blockers are reversible and safe to administer in children. Hormone
therapy is used to feminize or masculinize an individuals’ body who is experiencing
gender dysphoria and is considered a partially reversible treatment (WPATH, 2012).
Gender-affirming surgeries, such as “top”, “bottom”, and facial surgeries are irreversible
procedures that are medically necessary for some TGNB persons. In general, not all
TGNB persons seek gender-affirming medical treatment; some individuals may live as
their felt gender without any procedures, while others may need one or more genderaffirming procedures. However, it is important to note that if left untreated, gender
dysphoria can lead to other mental health complications, including anxiety, depression
and self-harm behaviours.
Access to gender-affirming medical care is essential for TGNB persons and can have a
major impact on their psychosocial well-being. In fact, there has been an increasing trend
in the number of referrals to gender identity clinics (Fielding & Bass, 2018; Handler et
al., 2019). A study in the U.K. reported that at a gender clinic located in Oxfordshire,
referrals had doubled in the past 6 years; there were 59 referrals in 2011-2013 and this
number increased to 103 referrals from 2014-2016 (Fielding & Bass, 2018). Moreover,
the mean age of TGNB persons referred to the clinic was significantly lower in more
recent years (2013-2016) compared to the first three years of the study (2011-2013). A
study in the U.S. also reported a significant increase in referrals between 2015 and 2018
where there were 56 referrals in 2015 compared to 194 in 2017 (Handler et al., 2019).
These findings remain consistent across Canada, where pediatric patient referrals have
increased exponentially from 2004 to 2016, with about a 10-fold increase from 20122016 (Lawson et al., 2017). Therefore, an increase in demand has been noted in several
countries which may result in increased wait-times to receive needed gender-affirming
care.
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It has already been reported that in British Columbia, TGNB individuals waited 150 days
or less between their referral and surgery assessment appointment, while TGNB persons
from other provinces/territories in Canada waited 180 days. Upon completion of this
appointment, there was another waiting period between surgery approval and the surgery
date which was eight months or less in Canada (Frohard-Dourlent et al., 2017). Long
wait-times were previously reported for hormone therapy as well. In Alberta, some
TGNB individuals have to wait up to six months to find a general practitioner that will
refer them to a psychiatrist, in which psychiatric wait-lists can then be even longer. There
is also another three to four month waiting period after to have an appointment with an
endocrinologist in order to receive a prescription (Rendell-Watson, 2017).
Several studies have noted the benefits and improvements in mental health outcomes
upon receiving gender-affirming care (Almazan & Keuroghlian, 2021; Baker et al., 2021;
Wernick et al., 2019; White Hughto & Reisner, 2016; Passos et al., 2020). A recently
published systematic review investigated the effects of hormone therapy on mental health
outcomes and quality of life among TGNB people of all ages (Baker et al., 2021). The
review concluded that there is evidence to suggest that hormone therapy may improve
quality of life, anxiety symptoms, and depressive symptoms among TGNB persons, with
no studies reporting negative psychological outcomes due to hormone therapy. This
finding was consistent across gender identities and age (Baker et al., 2021). Another
systematic review by Wernick et al. (2019) found that gender-affirming surgeries
provided improvements in psychological outcomes as well.
Furthermore, a study conducted in the Netherlands concluded that hormone therapy and
gender reassignment surgery significantly reduced gender dysphoria symptoms and
improved psychological outcomes (including anxiety and depression) in young adults
over time (de Vries et al., 2014). Importantly, it was reported that after gender-affirming
surgery, the wellbeing of TGNB persons in this study was similar or in some cases, even
better than that of the general population within the same age range (de Vries et al.,
2014). A study conducted in the U.S. examined the relationship between genderaffirming surgeries and mental health outcomes in a large sample of TGNB adults
(Almazan & Keuroghlian, 2021). The results suggested that having had one or more
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gender-affirming surgeries was associated with reduced psychological distress in the past
month, as well as lower past year suicidal ideation. A Canadian study by Bauer et al.
(2015) determined that among transgender persons who reported a need to receive
gender-affirming care, those who completed a medical transition (such as hormone
therapy and/or surgical procedures) had reduced suicidal ideation. A community sample
from the UK and Ireland also reported that suicidal ideation and attempts were reduced
after receiving gender-affirming care with 70% of TGNB persons reporting they were
more satisfied with their lives post transition (McNeil et al., 2012). Moreover, a
prospective cohort study conducted in Italy reported that hormone therapy was associated
with better mental health, in which both anxiety and depression was reduced for those
who were using hormone therapy (Colizzi et al., 2014). Therefore, several studies in
various countries have determined that there is a relationship between gender-affirming
care and improved mental health, including anxiety and depression, in TGNB persons
who require this form of care.

2.3 COVID-19 pandemic impact
On December 31st, the WHO was notified of cases of pneumonia with an unknown cause
discovered in Wuhan City, China (WHO, 2020b). The number of new cases continued to
increase rapidly and COVID-19 began spreading to various countries in a very short
period of time. On March 11th 2020, the WHO declared COVID-19 a global pandemic.
In the early months of the pandemic, government policy responses were very similar
world-wide (Hale et al., 2021). Most countries established various emergency measures
to mitigate and reduce the spread of COVID-19. It is important to note how quickly
governments had adopted these new policies. Hale et al. (2021) revealed that in early
March, extreme lockdown measures had not been implemented in the majority of
countries worldwide. However, by the beginning of April, the policy response of almost
every single country changed drastically; lockdown orders and new measures to curb the
spread of COVID-19 were quickly adapted globally. These measures resulted in changes
to day-to-day functioning for almost all individuals and led to disruptions world-wide,
including travel restrictions, increased contact tracing and quarantine requirements,
increased investment in medical equipment for healthcare facilities, reduced or cancelled
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healthcare services, workplace/business and school closures, bans on social
gatherings/events (e.g., weddings, concerts, sporting events), increased financial support
for those who may have lost their source of income and overall detrimental economic
impacts. In the next few months of the pandemic, these policies were eventually lifted or
eased in some countries however, in some instances, they had been reimposed; especially
when a resurgence of cases was of concern.
The closure of businesses and workplaces, including restaurants, fitness facilities and
retail stores, resulted in a financial loss for both business owners and their employees. To
mitigate the impact of these changes, some countries offered these businesses and their
employees financial aid. Specifically, in Canada, the Canada Emergency Response
Benefit (CERB) provided $2000 monthly to individuals who were directly impacted by
the COVID-19 pandemic. As the pandemic progressed, other forms of financial support
were provided to businesses and individuals who were directly impacted by the policies
that were imposed throughout 2020 and 2021 (Government of Canada, 2021). Support for
individuals and families included the Employment Insurance Program, Canada Recovery
Benefit, Canada Recovery Sickness Benefit, among others. The Canadian Government
also waived interest fees for students who had received federal loans. Additionally,
school closures resulted in students and teachers having to quickly adapt to learning and
teaching in an online format. Remote learning introduced other concerns and challenges
including, family violence and safety, food insecurity, availability of devices and internet
for children learning from home, and potential income impacts for parents who had to
reduce their work hours to support homeschooling (Statistics Canada, 2021b).
The COVID-19 pandemic also had an impact on the delivery of healthcare services.
Some health services that were previously provided in person were recommended to be
moved to an online format to mitigate the spread of the virus, such as follow-up visits
with physicians and psychological treatments, including support groups (WHO, 2020a).
Additionally, due to the potential influx of patients presenting to emergency departments
with COVID-19, there was an increased fear of hospital overcrowding. As a result,
elective procedures and surgeries had largely been cancelled (WHO, 2020a). “Essential”
health services were still being provided during this time in which the WHO identified
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priority categories and/or populations; this included but was not limited to immunizations
for communicable diseases, reproductive health services, services for vulnerable
populations (e.g., children and older adults), medications and services for the
management of chronic diseases, and acute health emergencies that require immediate
attention. Over a year into the pandemic, it was reported that 90% of countries were still
experiencing at least one interruption in essential healthcare services, which indicated no
major changes since the beginning of the pandemic (WHO, 2021).
The Canadian healthcare system also endured changes due to the COVID-19 pandemic
(Canadian Institute for Health Information [CIHI], 2020). For example, emergency
department visits, hospital care and physician services were largely affected. In
particular, there was a tremendous number of surgery cancellations reported which
directly impacted Canadians. From March to June 2020, there were approximately 335
000 fewer surgeries performed in Canada in comparison to the previous year (CIHI,
2020). Those who required medically urgent surgeries were likely to receive them as
planned however, there was a reduction in surgeries that were deemed less urgent.
Compared to the same time period in 2019, the first few months of the pandemic in 2020
resulted in a decrease in surgeries; this included 21% fewer knee and hip replacements, a
53% reduction in hernia repairs, 29% fewer retina repairs and 17% lower fracture repairs
(CIHI, 2020). There was also a disruption in cancer care in which there was a 20%
reduction in cancer surgeries performed during the first wave of the pandemic compared
to the same time frame in 2019. Moreover, Chen-See (2020) reported that approximately
50% of those receiving cancer care had their appointments cancelled or rescheduled due
to COVID-19 in Canada.
Disruptions in healthcare services likely impacted TGNB persons in Canada with regards
to gender-affirming care. It was reported that gender-affirming surgeries were cancelled
during the first wave of the pandemic (Provincial Health Services Authority [PHSA],
2020). By June of 2020, some elective surgeries had recommenced in hospitals and this
varied by province/territory (CIHI, 2020). Similarly, some gender-affirming surgeries
were resumed during this time as well (PHSA, 2020). It is important to note that prior to
the pandemic, there were already long wait-times for gender-affirming surgeries
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(Frohard-Dourlent et al., 2017). As a result, the COVID-19 pandemic will only
exacerbate the pre-existing wait-times and impact future surgeries. A recent brief report
by the Trans PULSE Canada study noted that TGNB persons in Canada also experienced
interruptions in their hormonal care due to the COVID-19 pandemic (Trans PULSE
Canada COVID Cohort Working Group on behalf of the Trans PULSE Canada Team,
2020). Therefore, the postponement of non-urgent healthcare services likely had an
impact on the availability of gender-affirming care for TGNB persons in Canada.
Similar to other emergency and crisis events, it is inevitable that there will be
psychological consequences due to the increased distress experienced from the COVID19 pandemic (WHO, 2019). Each individual may be impacted differently during a state
of emergency. In particular, the WHO (2019) reported that during humanitarian crises,
including epidemics, it is common to see anxiety and depression levels increase over twofold. Vulnerable populations who already experience severe mental disorders can be
disproportionally affected during and after emergency events; emphasizing the
importance of providing access to care for these individuals.
In Canada, there have already been increased concerns for the mental health of Canadians
amidst the pandemic. A report by the Canadian Mental Health Association (CMHA)
revealed that during the first wave of the pandemic, 38% of Canadians said that their
mental health worsened due to COVID-19 with 46% feeling anxious and worried
(CMHA, 2020a). Moreover, people who identified as LGBTQ2+ were more likely to
report a decline in mental health during this time period. Another study by CMHA that
took place during the second wave of the pandemic revealed that Canadians were still
experiencing heightened mental health challenges in certain subpopulations (CMHA,
2020b). Specifically, LGBTQ2+ individuals were experiencing increased mental health
challenges in comparison to the first wave of the pandemic (CMHA, 2020b). There are
several reasons why COVID-19 may be contributing to rising mental health issues in
Canadians. Some of these mental health challenges may be attributed to the uncertainty
about this novel virus, including an increased concern for one’s health, as well as the
health of other family members or loved ones, while other challenges may be attributed
to the policy changes. For example, due to mandated industry closures, some may be
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experiencing unemployment or income loss, school closures may result in the loss of a
safe and supportive environment for some students, and stay-at-home orders may result
in increased social isolation and domestic violence (CMHA, 2020c).

2.4 Current available research: COVID-19 impact on TGNB
mental health, social support, service disruptions and
gender-affirming medical care
2.4.1 COVID-19 impact on TGNB mental health
The current literature has shown that TGNB youth have generally been experiencing
heightened mental health problems in relation to the COVID-19 pandemic (Hawke et al.,
2021; Jones et al., 2021). In particular, increased anxiety and depression levels have most
often been reported. A Canadian study with a sample of 622 youth (29 identified as
TGNB and 593 identified as a man/boy or woman/girl) reported that TGNB youth had
significantly higher scores for mental health issues during COVID-19 compared to their
cisgender counterparts (OR=2.64, p-value=0.001) (Hawke et al., 2021). In the U.K., 161
TGNB youth participated in an online survey where they could describe their personal
experiences during COVID-19 via open-response questions (Jones et al., 2021). The
qualitative portion of the survey revealed that several youths had reported that their
anxiety and depression symptoms were exacerbated during the beginning of the
pandemic. However, there were also a small sample of youth that noted that their mental
health symptoms had improved due to the pandemic, most notably due to having more
free time to work on their mental health as well as having reduced social anxiety (Jones et
al., 2021).
TGNB adults have also been experiencing deteriorating mental health amidst the
pandemic. A global cross-sectional survey of TGNB adults (n=849) reported that
approximately 46% and 51% of their sample screened positive for anxiety and
depression, respectively (Restar et al., 2021). The U.S. PRIDE longitudinal study also
discovered depression and anxiety changes among SGM persons during the onset of the
COVID-19 pandemic (Flentje et al., 2020). For the 2288 participants included in the
study, depression symptoms increased by a Patient Health Questionnaire-9 (PHQ-9)
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score of 1.21 (t=11.35, p value <0.001) from pre- to post-pandemic. Anxiety symptoms
also increased by a General Anxiety Disorder-7 (GAD-7) score of 3.11 (t=27.95,
p<0.001) from pre- to post-pandemic. Interestingly, those who were not experiencing
symptoms consistent with generalized anxiety and depression pre-pandemic were the
individuals who were experiencing these increased anxiety and depression symptoms
post-pandemic (Flentje et al., 2020). Another U.S. study reported that compared to prepandemic anxiety and depression levels, a greater proportion of TGNB individuals met
the threshold for clinically significant symptoms of anxiety and depression during the
pandemic (Kidd et al., 2021). Importantly, a recent study on LGBTQ+ adults in the U.K.
has shown that TGNB individuals reported higher depression scores than their cisgender,
lesbian and gay counterparts during the pandemic (Kneale & Bécares, 2021). Therefore,
there is evidence to suggest that TGNB persons are experiencing mental health
complications amidst the pandemic—further emphasizing the importance of including
TGNB persons in COVID-19-related research efforts.

2.4.2 COVID-19 impact on social support and mental health services
for TGNB people
Studies have reported that TGNB persons are experiencing a lack of social support during
the pandemic (Hawke et al., 2021; Jones et al., 2021). A Canadian study by Hawke et al.
(2021) determined that TGNB youth are experiencing a lack of support from family
members during the pandemic, however this trend was not reported when examining
levels of support from friends or significant others. The authors concluded that this may
be as a result of living in unsupportive environments due to stay-at-home orders that have
been implemented (Hawke et al., 2021). Similarly, another study in the U.K. reported that
youth had lost sources of support and had challenges accessing support due to social
distancing guidelines (Jones at al., 2021). TGNB adults are also experiencing disruptions
regarding the social support they usually have available. The predominately European,
TransCareCOVID-19 study reported that of participants who were members of a support
group, 69.2% had limited access to them due to COVID-19 (Koehler et al., 2020).
The COVID-19 pandemic has also resulted in several service disruptions due to stay-athome orders. For the TGNB population, mental health service disruptions as well as
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reduced access to community support groups have been reported. Among TGNB
Canadian youth, approximately 70% reported a COVID-19-related disruption in mental
health or substance use service compared to 26% of cisgender youth (Hawke et al.,
2021). Moreover, a greater proportion of TGNB youth reported that their needs were not
met for mental health and substance use services compared to cisgender youth (63% vs.
28%). Although telehealth has become widely adapted in the COVID-19 era, it is
important to note that telehealth mental health services may not be ideal for TGNB
persons as they might experience social anxiety (e.g., in relation to their voice) which
prevents them from using online mental health interventions (Jones et al., 2021).
A cross-sectional global study of 964 TGNB adults reported that among gender-affirming
resources that they were using, mental health services was the most frequently disrupted
resource (Jarrett et al., 2021). Some TGNB persons rely on other services for informal
mental health support, for which it has been reported that there is also reduced access to
specific LGBTQ+ and TGNB supportive organizations due to the pandemic (Kidd et al.,
2021). A U.S. longitudinal cohort study of TGNB adults showed that over half of their
study sample had reduced access to LGBTQ+/TGNB supportive organizations due to the
pandemic. Moreover, this reduced access was linked to higher psychological distress
after controlling for pre-pandemic mental health levels (Kidd et al., 2021). Therefore, a
decrease in social support and additional service disruptions (in particular, mental health
services) may have a detrimental effect on TGNB people's mental health.

2.4.3 COVID-19 and interruptions in gender-affirming medical care
Due to the COVID-19 pandemic, some TGNB persons have been experiencing delays
and/or reduced access to gender-affirming medical care (Kidd et al., 2021). A study in the
U.K. reported that the majority of TGNB youth were worried about the COVID-19
pandemic impact on their transition process as many had difficulties accessing genderaffirming medical care (Jones et al., 2021). Some of these youths also reported feeling
social anxiety due to their inability to access gender-affirming medical care; in particular,
gender-affirming surgical procedures had been cancelled with no new rescheduled date
(Jones at al., 2021). A predominantly European, cross-sectional study of TGNB adults
revealed that among those who received or were planning to receive gender-affirming
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care, approximately 60% were concerned that future transgender health care would be
difficult to access due to the ongoing pandemic (Koehler et al., 2020). Moreover, about
half of the respondents who had already received some type of gender-affirming care had
experienced difficulties in accessing transgender healthcare services due to the pandemic.
For example, 21.8% reported that their access to hormones was currently restricted, with
another 15.6% and 19.5% reporting that their surgery was cancelled/postponed or that
they expect that it will be cancelled/postponed, respectively (Koehler et al., 2020). A U.S.
study also reported that 11.1% of TGNB participants in their study experienced a surgery
cancellation and 32.7% reported an interruption in hormonal care (Kidd et al., 2021). A
cross-sectional, global study of TGNB adults (n=849) determined that among the
participants who were receiving gender-affirming care prior to the pandemic, 33.2% and
31.1% experienced a reduction in hormone treatments and surgical after-care,
respectively (Restar et al., 2021). This same study also found that interruptions in genderaffirming care partially mediated the relationship between the impact of socioeconomic
loss and poor mental health outcomes during the pandemic.

2.4.4 Interruptions in gender-affirming medical care and mental
health
Before data had become available, commentaries and opinion pieces had expressed
concerns about the potential negative effects of delays in gender-affirming care due to
COVID-19 on TGNB mental health (Herman & O’Neill, 2020; Wang et al., 2020; van
der Miesen et al., 2020; Pearce et al., 2020). Due to the postponement of in-person
consultations and surgeries, TGNB persons could have difficulties in accessing hormone
therapy and/or gender-affirming surgeries (Wang et al., 2020), wherein a lack of access to
this care could result in increased suicidal ideation and attempts (Herman & O’Neill,
2020). Moreover, TGNB persons often have already overcome many barriers to schedule
their surgical procedures, including financial, legal and geographic obstacles (Roberts et
al., 2020). For example, in Germany, just the application process for top surgeries can
take anywhere from two to six months (Eickers, 2020). There are also limited surgeons
who specialize in these procedures which increases wait-times and can affect the mental
health of this population.
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Currently, there are a few studies that have investigated the association between delays in
gender-affirming medical care and mental health (Zwickl et al., 2021; Jarrett et al., 2021;
Kidd et al., 2021). A cross-sectional study of TGNB persons in Australia showed that
those who experienced cancellations in gender-affirming surgeries were more likely to
have thoughts of self-harm or suicide (Zwickl et al., 2021). A global, cross-sectional
study discovered a relationship between screening positive for depression and anxiety
and reduced access to gender-affirming resources (e.g., hormone therapy, surgery aftercare, mental health services, cosmetic supplies, body modifiers) due to the COVID-19
pandemic (Jarrett et al., 2021). When examining the relationship between genderaffirming care and suicidal ideation, the authors found a similar trend—among the
individuals who had rare or no suicidal ideation during the onset of the pandemic, those
who had experienced a loss of access to at least one gender-affirming resource reported
greater suicidal ideation (Jarrett et al., 2021). In contrast, a U.S. longitudinal cohort study
of TGNB individuals aged 16 or older did not find a significant relationship between
interruptions in gender-affirming care and greater psychological distress (Kidd et al.,
2021). Initially, while controlling for gender identity and age, interruptions in genderaffirming care due to the pandemic was associated with greater psychological distress.
However, after the investigators adjusted for pre-pandemic mental health, this
relationship was no longer significant (Kidd et al., 2021).

2.5 Potential implications of COVID-19 disruptions on
TGNB people and their mental health
With the potential of disruptions in hormonal prescriptions amidst the pandemic, an
increasing number of TGNB persons may search for alternative methods to acquire
hormones in order to prevent unwanted changes to secondary sex characteristics. Online
forums are frequently being used in the TGNB community for individuals seeking advice
for obtaining hormones as they begin to run short on supply (Edenfield, 2021). It is
important to note that online forums may provide advice that are not written by
physicians with medical expertise. Therefore, the medical advice provided could lead to
an increasing number of individuals exhibiting risky behaviours to acquire hormones,
which could be very dangerous and detrimental to their health. Van der Miesen et al.
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(2020) concluded that there will likely be an even greater delay for individuals seeking
gender-affirming care in the future due to the reduced capacity of healthcare systems and
cancellations of previous procedures. Given the relationship between gender-affirming
care and mental health, this may result in heightened mental health complications in the
TGNB population.
Not only can the pandemic impact gender-affirming care, but it can also contribute to an
increased difficulty in accessing needed health care among this population. Prior to the
pandemic, TGNB persons were already experiencing barriers when seeking health care,
including a deficiency of knowledgeable healthcare professionals in transgender health
and long wait times to see transgender-friendly providers (Wang et al., 2020; Carman et
al., 2020). This may be even more exacerbated due to social distancing measures
(Carman et al., 2020). Moreover, some TGNB persons have previously encountered
discrimination or discomfort when seeking care which may explain why some delay
seeking care or experience a lower quality of care (Pearce et al., 2020; Herman and
O’Neill, 2020). Delayed care and treatment results in a greater risk of developing serious
and life-threatening consequences of COVID-19. Additionally, TGNB persons may have
appointments with psychiatrists and/or therapists postponed or moved to an online format
(Eickers, 2020). This could lead to a decreased frequency and/or lower standards of
available mental health services for TGNB persons, especially if there is a lack of quality
in the telehealth being offered (van der Miesen et al., 2020). Given that TGNB persons
were already experiencing a greater level of mental health complications than the general
population, these difficulties in accessing needed health care can be detrimental to their
mental well-being.
The closure of businesses, office spaces and schools has resulted in an increased number
of individuals working and studying from home, including TGNB persons. The ability to
work from home has resulted in positive experiences for some TGNB individuals, while
others have experienced increased distress due to this change in environment. Some
TGNB persons might enjoy working from home because they are able to use their
bathroom at home, rather than having to decide whether they can use the bathroom that
reflects their gender identity at their current workplace (Konnoth, 2020). In contrast,
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some may have negative experiences working from home. For example, since in-person
conversations can no longer take place, phone calls may be used more frequently to
communicate. As a result, TGNB persons may get misgendered on telephone calls
because the individual on the other line can only listen to their voice and cannot see their
physical appearance (Konnoth, 2020).
School closures can also have a negative impact on TGNB youth who must go home to
families that are unsupportive of their gender. This is especially harmful for youth who
have peer support at school and frequently use the mental health programs offered
(Salerno et al., 2020). Additionally, some businesses have opted to completely close due
to the economic strain caused by the pandemic, resulting in job losses and an increase in
unemployment. The 2015 U.S. Transgender Survey revealed that the unemployment rate
for transgender persons was already three times higher compared to the general U.S.
population (James et al., 2016). Transgender respondents were also more likely to live in
poverty compared to the U.S. population (29% vs. 12%). Given that lower socioeconomic
status has been previously associated with a higher prevalence of health risks (Stronks et
al., 1998), TGNB persons may be at a greater risk of both the short and long-term
implications of the COVID-19 pandemic. Aside from unemployment and income
affecting both financial stability and physical health, it also may result in increased
mental health issues for TGNB persons who rely on employment insurance to cover their
gender-affirming medical care (van der Miesen et al., 2020).
Stay-at-home orders and social isolation may be detrimental for TGNB individuals,
specifically for those who have unsupportive families or are at a greater risk for partner
violence (Herman & O’Neill, 2020). One study discusses how social distancing can have
negative implications on the mental health of SGM populations (Phillips et al., 2020). For
example, factors contributing to minority stress can become more prevalent during the
pandemic, including poor social support. A supportive network can include people
outside of one’s household, such as friends, teachers, co-workers, and community groups
and organizations. With the ongoing pandemic, TGNB persons may be experiencing even
greater levels of social exclusion due to separation from supportive individuals who are
not living in their household and reduced availability of safe spaces (Carman et al., 2020;
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van der Miesen et al., 2020). It is important to note that TGNB persons may not solely
rely on medical professionals for mental health services; local community centres and
organizations can also provide mental health support for these individuals (Eickers,
2020). However, many of these organizations were not able to operate due to COVID-19
measures. Therefore, this can result in a decrease in social support and acceptance for
TGNB persons who do not have a solid support system at home. Eickers (2020) also
noted that social isolation, which may result from a combination of both difficulties
accessing TGNB specific health care and reduced social support, can have a negative
impact on the mental well-being of transgender individuals; especially for those who
were already suffering from mental health complications pre-pandemic.
Furthermore, social distancing guidelines can have an indirect effect on substance abuse
as individuals may turn to alcohol and/or drugs as a coping strategy since there are less
supportive resources available during these unprecedented times (Carman et al., 2020).
There is some evidence to suggest that alcohol and drug abuse is more prevalent in
LGBTQ+ populations compared to the broader population (Ritter et al., 2012; Roxburgh
et al., 2016). In particular, substance abuse among transgender persons has been
previously linked to increased stigma and social exclusion (Scheim et al., 2017). A
Canadian study reported that approximately 12% of the transgender population in Ontario
used at least one high-risk drug in the past year, in which transgender persons were also
more likely to use both cocaine and amphetamine compared to the non-transgender
population (Scheim et al., 2017). Given that social exclusion has previously been linked
to drug use, this could potentially result in increased substance abuse during the
pandemic and additional physical and mental health complications for this population.
Overall, there is very limited research that has examined the relationship between
interruptions in gender-affirming care due to COVID-19 and mental health. The majority
of the existing literature consists of cross-sectional studies and opinion pieces which
make it impossible to determine causation. Moreover, a recent longitudinal study
reported contradicting results with regards to this association when compared to the other
cross-sectional studies, demonstrating a further need to assess this relationship with
longitudinal data. Many of these studies were also conducted outside of Canada which
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reduces the generalizability to the Canadian population. Importantly, some researchers
who have investigated this relationship have called for future research with longitudinal
data to better understand the relationship between interruptions in gender-affirming care
due to COVID-19 and mental health (Restar et al., 2021). Given the limited longitudinal
research that is available and the lack of research that has included the TGNB Canadian
population, this current study has the unique opportunity to longitudinally examine the
impact of interruptions in gender-affirming care due to COVID-19 on anxiety and
depression among TGNB people in Canada.

26

Chapter 3

3

Methods

This chapter will provide an overview of the study sample, the variables included in the
analysis and how they were measured, along with statistical analyses that were
performed.

3.1 Study sample
Trans PULSE Canada was a national community-based survey funded by the Canadian
Institutes of Health Research (CIHR) that focused on the health and well-being of
transgender and non-binary people in Canada. In particular, the Trans PULSE Canada
study seeks to describe and compare health outcomes and access to healthcare among
transgender and non-binary people across different provinces/territories, as well as
gathering additional information on nine priority population groups (individuals with
disabilities, Indigenous persons, sex workers, non-binary individuals, racialized persons,
those living in a rural location, immigrants and newcomers, youth and older adults). To
be eligible to participate, individuals had to be over the age of 14, reside in Canada, and
identify as a gender other than what they were assigned at birth. To recruit participants in
the study, the majority of the promotion took place through social media (e.g., Trans
PULSE Canada website, Facebook, Twitter) and community organizations. There were
also eleven peer research associates (PRA) hired across Canada who promoted the
questionnaire locally and were available to collect data in person via tablets.
The Trans PULSE Canada study was originally designed as a multi-mode national crosssectional survey. However, given the situation with COVID-19 in 2020, the research
team decided to create a new COVID-19 related survey which would capture how the
pandemic had impacted the lives of TGNB persons in Canada—this new study was called
the Trans PULSE COVID Cohort. As a result, this thesis is a longitudinal study using
both the 2019 and 2020 datasets. To be eligible to participate in the 2020 survey,
individuals had to have participated in the Trans PULSE Canada survey in 2019 and they
had to be currently living in Canada. To recruit participants, an invitation was sent to
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those individuals who had provided contact information and consent for recontact in the
2019 survey. Each participant was recontacted via phone, email or mail depending on the
information provided on the previous survey.
For the Trans PULSE Canada survey in 2019, data were collected for ten weeks in the
summer of 2019. Participants could complete the questionnaire online, in paper or over
the phone in either English or French. There was also the option to complete the
questionnaire via phone with a language interpreter. Two versions were available for
participants—a longer questionnaire and a short form. The full-length questionnaire
focused on many aspects of health and well-being, including questions on genderaffirming care, experiences with health services, physical and mental health status, social
support, gender positivity and distress, and identity documents. Participants were able to
save and exit the online questionnaire at any time if they were unable to complete it in
one sitting, as well as schedule multiple sessions if the questionnaire was being
completed via phone or in-person with a PRA. The short-form questionnaire was
available to those who were unable or were not willing to complete the longer version of
the questionnaire and it included questions on demographics, along with one key question
from each major section in the full-length questionnaire. At the end of the questionnaire,
participants were given the opportunity to provide contact information if they were
willing to be recontacted for potential future studies. However, this was not a requirement
to participate in the study. For those who provided contact information, the contact
information and questionnaire answers were stored separately. Additionally, there was no
honorarium for completion of the questionnaire.
All data were stored on REDCap servers at Western University. REDCap is a highly
secured web application used for surveys and databases. Research Ethics Board (REB)
study approval was obtained from the Unity Health Toronto Research Ethics Board at St.
Michael’s Hospital, the Human Research Ethics Board at University of Victoria, NonMedical Research Ethics Board at Western University, and the Research Ethics Board of
Wilfrid Laurier University. Given that youth were also able to participate in the study, it
is important to note that parental/guardian consent was waived for youth under the age of
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18 in order to protect the safety of transgender and non-binary youth who may have not
disclosed their gender identity to their parents or others.
For the Trans PULSE COVID Cohort, data were collected for approximately four weeks
in the fall of 2020. Eligible participants were able to complete the questionnaire online or
in paper format. If there were any issues with accessing the questionnaire due to
communication difficulties (e.g., if they had used translators for the 2019 questionnaire),
those individuals were directed to contact the project coordinator or principal
investigators who would aid in providing appropriate accessibility. The Trans PULSE
COVID questionnaire included sections on sociodemographics, healthcare access
(primary, emergency, gender-affirming care etc.), physical and mental health status,
COVID-19 testing and care, as well as access to community and social support. Some
questions used standardized study instruments, while others were adapted from the
TransCare COVID-19 questionnaire and Statistics Canada population questionnaires.
Participants were able to pause the online and paper questionnaires and restart at a later
time if needed. At the end of the questionnaire, they were also able to update the contact
information that was provided in the 2019 questionnaire. A $20 gift card honorarium was
given to participants upon completion (President’s Choice, Amazon.ca, Tim Horton’s or
Indigo).
All data were securely stored on REDCap servers at Western University and REB study
approval was obtained from the Institutional Review Board at Drexel University, the
Non-Medical Research Ethics Board at Western University, the Human Research Ethics
Board at University of Victoria and the Research Ethics Board at Wilfrid Laurier
University. Lastly, in contrast to the sharing protocol for the Trans PULSE Canada data
which only allowed de-identified data to be accessible to the team’s Data Analysis
Working Group, anonymized data from the COVID cohort will be made available to the
public.
There were a total of 3524 questionnaires completed in 2019. Observations were deleted
if they were (1) identified as non-participants (e.g., team members entering the online
questionnaire for testing), (2) those who logged in but did not start the questionnaire, (3)
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bots and trolls or (4) duplicate entries. As a result, the following observations were
deleted: 8 questionnaires as they were non-participant entries, 527 due to incompletion of
multiple key early demographic questions (age, ethnoracial identity, person of colour,
immigration, sex assigned at birth, gender identity category), 2 due to trolls and 114 were
duplicate entries. This resulted in a final sample size of 2873 in 2019. Of the total 2873
final study participants, there were 2870 that were completed online or in paper, 0 by
telephone, and 3 were administered by PRAs (all in English). Of the participants who
completed the questionnaire in 2019, there were 1184 who had provided consent for
recontact however, the contact information was invalid for some individuals. Therefore,
of those who had valid information and were contacted for the Trans PULSE COVID
Cohort, there were a total of 826 survey respondents. Observations were removed if
consent was not provided on the questionnaire. All questionnaires were completed online.
This resulted in a final sample size of 820 for the 2020 data collection period.
This thesis is a longitudinal study using both the 2019 pre-pandemic and 2020 pandemic
datasets in order to assess the impact of interruptions in gender-affirming care during
COVID-19 on changes in anxiety and depression among Trans PULSE Canada
participants. Individuals were included in the study if (1) they completed both the 2019
full questionnaire and 2020 COVID questionnaire, (2) at the time of the 2019 survey,
were aged 14 or older, lived in Canada and identified as a gender other than what they
were assigned at birth (general criteria from the 2019 survey), and (3) at the time of the
2019 survey, they either had completed, were in process, or were planning to receive
gender-affirming care. Those who were not planning to receive gender-affirming medical
treatment or were not sure whether they would seek gender-affirming medical treatment
in 2019 were excluded. As a result, there were 611 survey respondents included in the
final analytic sample for this study.

3.2 Directed acyclic graphs
Directed acyclic graphs (DAGs) offer a visual representation of the causal relationships
between dependent and independent variables while also providing the association of
these variables with other covariates. In particular, DAGs can be used to determine
whether other covariates might confound the relationship between the exposure and
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outcome. A variable is a confounder if it has the ability to distort the true relationship
between an independent and dependent variable by playing a causal role in the outcome
of interest and having an association with the exposure. By using DAGs, one can
determine minimally sufficient adjustment sets— the minimum set of confounder
variables one needs to adjust for to measure a causal relationship without the risk of
confounding bias (Foraita et al., 2014).
For some research questions, the construction of a DAG can become very complex; this
in turn has resulted in the production of the online web application known as DAGitty
(Textor et al., 2016). This application allows the user to easily draw DAGs to determine
minimum sufficient adjustment sets for their research question of interest. To determine
what variables might be relevant to include in the DAG, one can use previous research
found in the literature, a priori knowledge, along with other information such as theories
or expert opinions (Foraita et al., 2014). For this thesis, DAGitty was used to determine a
minimum sufficient set of confounders to adjust for in order to measure an unbiased
association between interruptions in gender-affirming care and the outcomes, anxiety and
depression (Figure 1). For our DAG, we decided to include both outcomes, anxiety and
depression, in order to determine a common minimum sufficient adjustment set that
could work for both models. Previous literature was used to determine other risk factors
that may play a causal role in anxiety and depression. Given the limited research
available on this topic, a priori knowledge was also used to determine relevant variables
to include in the DAG. Both measured and unmeasured variables that were relevant in
assessing the relationship between interruptions in care and anxiety and depression were
included in the DAG by the user. DAGitty also allows users to force adjustment for
specific covariates that they would like to be included in every adjustment set (Textor,
2011). For this thesis, the specific covariates that we wanted to include (pre-pandemic
anxiety and depression) were already included in the eight possible minimal sufficient
adjustment sets that DAGitty had created; therefore, we did not need to force adjustment.
To select our final adjustment set from the eight options that DAGitty provided, we
prioritized a set that did not include unmeasured variables, had a smaller number of
covariates to adjust for and variables with minimal missing data (Austin et al., 2019). As
a result, the minimum sufficient adjustment set included the following variables: change
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in income due to COVID-19, current geographic location (province/territory), current
social support, educational attainment, fear of COVID-19 (COVID-19 related health
concerns), household poverty past year (low-income household), pre-pandemic anxiety
and depression and pre-pandemic gender-affirming care status (2019).
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Figure 1
Directed acyclic graph (DAG) of the relationship between interruptions in genderaffirming care and anxiety and depression
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3.3 Study measures
3.3.1 Exposure variables
Interruptions in gender-affirming care. Three variables from the Trans PULSE
COVID Cohort questionnaire were used to create a composite variable on interruptions in
gender-affirming care. The first focused on interruptions in taking hormones: “Since
March 12, 2020, have you had interruptions in taking hormones?”. The potential response
options were “Yes” or “No”. This question was only asked to those participants who take
hormones. The second focused on inability to get a new prescription for hormones:
“Since March 12, 2020, have you been unable to get a new prescription or referral for
hormones?”. There were three response options: “Yes,” “No,” and “I haven’t needed this
during this time”. Both of these items were developed by the Trans PULSE Canada
Team. The final variable focused on surgery interruptions: “Have you had a surgery
appointment canceled or postponed due to the current COVID-19 outbreak?”. Possible
responses were “Yes,” “No,” and “Not yet, but I expect it will”. This was only asked to
participants who had a gender-affirming surgery booked before March 12, 2020. This
questionnaire item was adapted from the TransCare COVID-19 project (TransCare
Hamburg, 2020) — an international, online survey that focused on how transgender
persons have been affected by COVID-19 in terms of physical health, mental health and
transgender health care.
For the composite variable, participants were categorized into four groups: (1)
interruptions in taking hormones, (2) surgical interruptions, (3) interruptions in taking
hormones and surgical interruptions, and (4) no interruptions in gender-affirming care.
Those who had interruptions in taking hormones and those who were unable to get a new
prescription or referral for hormones were grouped together as having “interruptions in
taking hormones”. Those who answered “Yes” or “No” to the items were categorized into
the appropriate interruption group. Additionally, those who had responded “Not yet, but I
expect it will” for surgical interruptions or “I haven’t needed this during this time” for
inability to get a new prescription for hormones were categorized as not having an
interruption.
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3.3.2 Outcome variables
Anxiety. The Overall Anxiety Severity and Impairment Scale (OASIS) was used to
measure self-reported pandemic anxiety levels. Developed by Norman et al. (2006), the
OASIS is a continuous measure that can be used to measure the severity of any anxiety
disorder, assess the severity and impairment across multiple anxiety disorders, as well as
capture subthreshold anxiety symptoms. It was designed to be a very brief questionnaire
so that it could be used in many different settings, ranging from a primary care
environment to population-based research studies (Campbell-Sills et al., 2009). OASIS is
a five-item scale that consists of the following questions: (1) In the past week, how often
have you felt anxious?, (2) In the past week, when you have felt anxious, how intense or
severe was your anxiety?, (3) In the past week, how often did you avoid situations,
places, objects, or activities because of anxiety or fear?, (4) In the past week, how much
did your anxiety interfere with your ability to do the things you needed to do at work, at
school, or at home?, (5) In the past week, how much has anxiety interfered with your
social life and relationships? To answer these questions, respondents are asked to
consider all of their experiences (e.g., panic attacks, situational anxieties, worries) and
include all of their anxiety symptoms. For each item, a 5-point Likert-type scale is used
with the scores ranging from 0-4; the scores for each item are added to represent a total
score (ranges from 0-20). A higher score indicates greater anxiety severity and
impairment, with a cut-point of eight or higher indicating a probable anxiety disorder.
OASIS is a validated measure used in many different populations and settings, ranging
from a non-clinical sample of college students to diverse clinical samples in the U.S. and
other multicultural populations (Campbell-Sills et al., 2009; Norman et al., 2006;
Hermans et al., 2015).
Depression. The 10-item Centre for Epidemiological Studies Depression Scale (CES-D10) was used to measure self-reported pandemic depression levels. The original CES-D
consists of 20 items and has been widely used to identify both clinical and non-clinical
depressive symptoms in diverse populations (Radloff, 1977; Shinar et al., 1986).
However, due to the length of the 20-item scale, both clinicians and survey researchers
are sometimes reluctant to use the full-length scale. A shorter version of the original
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CES-D scale was derived in which 10 of the 20 items are used to assess depressive
symptomology in the past week (Andresen et al., 1994). In order to shorten the scale,
items that did not have high correlations to the total score or items that were highly
correlated with each other and therefore repetitive were removed (Andresen et al., 1994).
As a result, there are three items on depressed mood, five items on somatic symptoms,
and two on positive mood (Baron et al., 2017). The CES-D-10 uses a 4-point Likert-type
scale where items are scored from 0-3, wherein 0 is “Rarely or none of the time” and 3 is
“Most or all of the time”. The score is reversed for 2 items (5 and 8) which represent
positive mood. A final score is determined by totaling the scores of each item; the
possible range for the final score is 0-30. A higher score represents greater depressive
symptoms, with a cut-point of ten or higher indicating depressive symptoms consistent
with clinical depression (Andresen et al., 1994). The CES-D-10 has proven to have strong
psychometric properties, demonstrating good reliability in community samples and
varying populations, including older adults and adolescents (Irwin et al., 1999; Cheung et
al., 2007; Bradley et al., 2010).

3.3.3 Descriptive characteristics
Age. In the questionnaire, participants were asked how old they were in years. For this
thesis, age was coded into six categories: “14-19”, “20-24”, “25-34”, “35-49”, “50-64”,
“65+”, as well as 3 categories: “14-24”, “25-49”, and “50+” for descriptive analyses. The
three-group age variable was created as it includes two meaningful Trans PULSE Canada
priority populations—youth and older adults.
Gender. Participants were asked about their current gender identity with the following
response options: “Man or boy”, Woman or girl”, “Indigenous or other cultural gender
identity (e.g., two-spirit)” or “Non-binary, genderqueer, agender, or a similar identity.”
Sex assigned at birth. Participants reported their sex assigned at birth as “Male” or
“Female”.

36

Province/territory. Participants were asked what province or territory they currently
lived in. For this thesis, the three territories were grouped together for analyses due to
small sample sizes.
Indigenous status. A binary variable for Indigenous status was created. All participants
were asked about their ethnoracial background. Those who selected “Indigenous” were
asked a follow-up question on which group they belonged too. Responses that included
“First Nations (status)”, “First Nations (non-status)”, “Métis”, “Inuk”, or “Indigenous
from Canada, don’t know which group” were categorized as “Indigenous”. Participants
who did not select “Indigenous”, or who responded “Indigenous from another country” or
“Unsure” to the follow-up question, were categorized as “Not Indigenous”.
Racialization. A binary variable for racialization was created using two items from the
questionnaire: “Are you perceived or treated as a person of colour in Canada?” and “Do
you identify as a person of colour?”. Response options for these variables were “Yes” or
“No”. Individuals were coded as “Racialized” if they responded yes to one or both of
these items and “Not Racialized” if they did not.
Immigration history. In the questionnaire, participants were asked “What country were
you born in?”. Possible response options were “Canada”, “Outside of Canada” or
“Unsure”. A binary variable was created to represent immigration history, in which those
who were born outside of Canada were classified as being an “Immigrant”.
Urban/rural. There were two questions in the questionnaire pertaining to postal code.
The first asked participants for their postal code for where they live or get mail. For those
who did not want to share their full postal code, there was also an option to share just the
first three digits. Both postal code questions required a write-in response. To code a
binary variable for living in a rural area, Community Size was used to determine rurality.
Community Size was derived from the census metropolitan area/census agglomeration
designation. Postal Code Conversion File Plus (PCCF+) version 7B was used to assign
the postal codes to communities’/census areas (Statistics Canada, 2018). Those living
outside of census metropolitan areas and census agglomerations were coded as living in a
rural area or small town (less than 10 000 people).
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Education. Survey respondents were asked about the highest level of formal education
that they have completed. There were 13 response options, ranging from “Some
highschool, no diploma or GED” to “Doctoral or professional degree”. For this thesis,
responses were coded into five groups: “<Highschool”, “High school diploma”, “Some
college or university or CEGEP”, “College or university degree, or CEGEP degree,
including those with some grad school, no degree”, or “Grad/professional degree,
including those who reported some Doctoral/professional work, no degree”.
Income. Participants were asked about their total personal income, before taxes and other
deductions from all sources in 2019. There were 13 response options, ranging from “Less
than $10,000” to “$150,000 or more”. There were also response options for those who
did not have or were unsure of their personal income. For the purposes of this thesis,
personal income was grouped into the following categories: “No personal annual
income”, “<$15,000”, “$15,000-$29,999”, “$30,000-$49,999”, “$50,000-$79,999”, or
“$80,000+”.

3.3.4 Confounder variables – minimum sufficient set
Income changes due to COVID-19. The questionnaire asked respondents aged 16 or
older “How much of an impact did the COVID-19 pandemic have on your personal
income from employment?”. The response options included “Major negative impact”,
“Moderate negative impact”, “Minor negative impact”, “No impact”, “Minor positive
impact”, “Moderate positive impact”, “Major positive impact”, or “Too soon to tell”. For
this thesis, responses were coded into three groups: “Positive impact”, “Negative impact”
or “No impact/too soon to tell”. This item was adapted from Statistics Canada (Statistics
Canada, n.d.).
Current social support. To measure available social support, the eight-item modified
Medical Outcomes Study Social Support Survey (mMOS-SS) was used (Moser et al.,
2012). Participants were asked "How often is each of the following kinds of support
available to you right now?”. There were 8 items included in the mMOS-SS survey such
as, “Someone to help you if you were confined to bed”, “Someone to take you to the
doctor if you needed it”, “Someone to have a good time with” etc. For each item, a 5-
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point Likert-type scale is used with the scores ranging from 1-5 where 1= “None of the
time”, 2= “A little of the time”, 3= “Some of the time”, 4= “Most of the time”, and 5=
“All of the time”. The final social support score is determined by computing the average
of the scores for all eight items included. A higher score indicates more support
(Sherbourne & Stewart, 1991).
COVID-19 related health concerns. Participants were asked about their concerns
during the COVID-19 pandemic in regard to their own health, “How concerned are you
about each of the following impacts of COVID-19? … My own health”. The response
options were “Not at all”, “Somewhat”, “Very” or “Extremely”. This measure was
adapted from Statistics Canada (Statistics Canada, n.d.).
Low-income household. This measure was derived according to Statistics Canada’s
Low-Income Measure (Statistics Canada, 2021a) using two questions from the
questionnaire pertaining to total income from all members living in the household and the
number of people supported on the household income. The Statistics Canada LowIncome Measure (LIM) determines low-income households and adjusts household
income by the number of people supported on the income. As such, there are different
LIM thresholds for different household sizes. Therefore, the LIM compares all the
participants’ incomes to the average person’s income while adjusting for household size;
those who had fallen below the LIM thresholds were coded as “Low-income household”
and those who did not were coded as “Not in a low-income household”.
Pre-pandemic anxiety and depression. Pre-pandemic depression and anxiety measures
were coded the same way as the anxiety and depression outcome measures using data
from the 2019 questionnaire.
Pre-pandemic gender-affirming care status (2019). Participants were asked “Which of
the following applies to your current situation regarding puberty blockers, hormones,
and/or surgery?” with the following response options, (1) I have had the gender-affirming
medical treatment I need/want, (2) I am in the process of completing gender-affirming
medical treatment, (3) I am planning to receive gender-affirming medical treatment, but
have not begun, (4) I am not planning to receive gender-affirming medical treatment, or
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(5) I am not sure whether I am going to seek gender-affirming medical treatment. For this
thesis, those who were not planning or not sure whether they would seek genderaffirming medical treatment were excluded.

3.3.5 Descriptive variables pertaining to gender-affirming care
Most items in the questionnaire that were used to describe gender-affirming care were
developed by the Trans PULSE Canada Team, unless otherwise stated.
Gender-affirming care status in 2020. The same item used to measure pre-pandemic
gender-affirming care status in 2019 was used to measure gender-affirming care status in
2020.
Take hormones. Respondents who said they have had or were in the process of
completing gender-affirming medical treatment were asked if they take hormones
(yes/no).
Current access to hormones. For those who said they take hormones, they were also
asked if they currently have access to hormones (yes/no).
Interruptions in taking hormones. Participants who said they take hormones were
asked whether they had interruptions in taking hormones since March 12, 2020 (yes/no).
Reasons for inability to access hormones. This item was asked to participants who said
they had interruptions in taking hormones. Response options included “Couldn’t afford
it”, “Couldn’t go to the pharmacy”, “Couldn’t get my prescription renewed”, “Couldn’t
get syringes or needles”, “Drug shortages”, “Nobody to help with injections”, “People in
my household couldn’t know I’m taking hormones”, and “Other”.
Unable to get new prescription for hormones. Those who were planning or in the
process to receive gender-affirming medical treatment were asked if they were unable to
get a new prescription or referral for hormones since March 12, 2020. Responses
included “Yes”, “No”, and “I haven’t needed this during this time”.
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Unable to get new prescription for hormones because of COVID-19 restrictions. For
those who were unable to get a new prescription or referral for hormones, they were
asked whether this was because of restrictions related to COVID-19 (yes/no).
Booked appointment for gender-affirming surgery. Those who were planning or in the
process to receive gender-affirming medical treatment were asked if they had an
appointment booked to have a gender-affirming surgery in the future before March 12,
2020 (yes/no).
Surgery appointment canceled due to COVID-19. Those who had a surgery booked
were asked whether they had a surgery appointment canceled or postponed due to the
current COVID-19 outbreak. Responses included “Yes”, “No” and “Not yet, but I expect
it will”. This questionnaire item was adapted from the TransCare COVID-19 project
(TransCare Hamburg, 2020).
Alternate date set for surgery. For participants who experienced surgery cancellations,
they were asked whether an alternative date was set for the surgery (yes/no). This
questionnaire item was adapted from the TransCare COVID-19 project (TransCare
Hamburg, 2020).
Type of surgery cancelled. For those who had a surgery appointment cancelled, they
were asked what type of surgery was cancelled or postponed. Response options included
“Chest surgery”, “Genital gender-affirming surgery”, “Removal of uterus (hysterectomy)
or removal of ovaries (oophorectomy)”, “Voice surgery”, “Adam’s apple surgery”,
“Facial surgery”, and “Other surgery”. This questionnaire item was adapted from the
TransCare COVID-19 project (TransCare Hamburg, 2020).
Had this surgery. Participants who had a surgery appointment canceled or postponed
due to COVID-19 were asked whether they had this surgery yet (yes/no).
Limited access to gender-affirming health care. All respondents were asked whether
the COVID-19 outbreak limited their access to the following aspects of gender-affirming
health care: (1) Binders, packers, or gaffs, (2) Non-medical supplies, (3) Medical material
that is important after surgery, and (4) Post-operative care following gender-affirming
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surgery. Response options included “Yes”, “No” and “Not applicable”. This item was
adapted from the TransCare COVID-19 project (TransCare Hamburg, 2020).

3.4 Data considerations
3.4.1 Sample merging and weights
The 2019 and 2020 datasets were merged into one working dataset before conducting any
analyses. Participants who had not completed the 2020 COVID questionnaire were
removed. For this thesis, weights were applied to all descriptive and regression analyses
to ensure that the 2020 survey data would represent the sample from the 2019 survey.
Sampling weights were provided by the Trans PULSE Canada team. Variables that were
included in the weights were chosen by looking at the differences in the distribution
between survey respondents who completed the full length 2019 questionnaire and the
2020 questionnaire. The sample weights for the population ranged from 0.40 to 2.50.
Overall, the weighted analyses were used to mitigate biases related to 2019 survey
completion, consent for re-contact, reachability and COVID-19 survey participation.

3.4.2 Missing data
536 of 611 survey respondents had complete data for all variables while 75 (12.3%) were
missing data for one or more variables. There were no missing data for interruptions in
gender-affirming care, anxiety and depression at time point 2, province/territory of
residence, educational attainment, social support and gender-affirming care status in
2019. However, other covariates that were included in the regression analyses were
missing. By looking at Table 1, we can see that the percentage of missingness for each
individual variable was relatively low. The categorical/binary variables that had missing
data included COVID-19 related health concerns with 0.16% missing, income changes
due to COVID-19 with 1.15% missing and the low-income household measure with
6.87% missing. Two continuous covariates, pre-pandemic anxiety and depression, both
had 5.89% missing data.

42

Table 1
Missingness for the confounder variables
Variable

Missing observations (n)

Percent Missingness (%)*

COVID-19 related health concerns

1

0.16%

Income changes due to COVID-19

7

1.15%

Low-income household

42

6.87%

Pre-pandemic anxiety

36

5.89%

Pre-pandemic depression

36

5.89%

*Note: This was calculated using a denominator value of 611 which is the analytic sample for this thesis.

Bennett (2001) suggested that when the proportion of missing data is greater than 10%,
statistical analyses have the potential to become biased. In this thesis, missingness was
below 10% for all variables, however given that there were missing data for a few
different variables, a concerning proportion of the sample would be excluded if a
complete case analysis was performed for the regression analyses. It was decided that the
loss of 75 observations might be substantial in terms of impacts on power and precision
(Sterne et al., 2009). Therefore, multiple imputation was used in the regression analyses.
Multiple imputation is commonly used due to its robustness and practicality in dealing
with missing data (Berglund & Heeringa, 2014). It has been adapted for use in many
commonly used statistical packages, including SAS. Multiple imputation uses the
distribution of observed data from other variables to estimate multiple values that are
plausible for the missing data (White et al., 2011). There are different methods to
multiply impute missing data in SAS. To determine the optimal method for this thesis, we
considered the pattern and type of data we were working with. Upon examination of the
missing data pattern, it was determined that there was an arbitrary missing data pattern
which the Fully Conditional Specification (FCS) and Markov chain Monte Carlo
(MCMC) methods could accommodate (Berglund & Heeringa, 2014). For this thesis,
there were missing data for both continuous and classification variables. To use the
MCMC method with classification variables, a rounding technique must be used to
impute these variables. This was not recommended because the FCS method has the
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ability to accommodate mixed variable types without post-imputation rounding.
Therefore, given the data pattern and types of variables we were using in the analyses, we
decided the FCS method would be most appropriate (Berglund & Heeringa, 2014).
The SAS procedure, PROC MI, was used to impute the missing data with the FCS
method. A random seed value (SEED=1180431796) was assigned and the number of
imputations were specified in this step. Overall, the recommended number of imputations
varies in the literature, however a larger number is usually preferred. For low proportions
of missing data, it has been reported that between 5 and 20 imputations is appropriate
(UCLA Statistical Consulting Group, n.d.). Therefore, we decided to choose 20
imputations given that the only burden of choosing the higher number of this range is
increased computational processing (Berglund & Heeringa, 2014). To impute missing
data for the select variables, the FCS LOGISTIC command was used for ordinal
variables, FCS DISCRIM for nominal variables and FCS REGRESSION for continuous
variables. PROC MIANALYZE was then used to combine the results from the 20
imputed datasets and to produce valid inferences (Berglund, 2015).

3.5 Statistical Analysis
All analyses were performed using SAS software, version 9.4.

3.5.1 Objectives 1 and 2: descriptive statistics
To determine the distribution of descriptive statistics and demographics for the entire
sample, as well as for each of the four interruptions in gender-affirming care subgroups,
the command PROC SURVEYFREQ was used for all classification variables. The
WEIGHT statement was also added to compute all frequencies. The SAS survey
procedures were selected for this thesis due to the complex nature of the survey data. For
example, the SAS survey procedures allow the user to take into account the complex
sample design in their analyses which might include stratification, clustering and unequal
weights (Nadimpalli et al., 2012). For other SAS procedures, including PROC FREQ, the
inferences made are based on assumptions such as simple random sampling and
independence of observations. However, when working with survey data with a complex
sample design, these assumptions may no longer hold. For this thesis, unequal weights
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were used and it is suggested that SAS survey procedures (e.g., PROC SURVEYFREQ)
are used when conducting analyses with unequal weights (Vandenbroucke, 2017).
Additionally, since we were only interested in a subpopulation of the participants, a
domain analysis was performed for all analyses. According to Lewis (2013), completely
restricting a dataset to a subpopulation of interest is risky prior to performing SAS
SURVEY procedures; the use of a BY statement was also cautioned against because both
can result in incorrect inferences. Lewis (2013) mentions that subsetting the dataset and
performing a domain analysis will produce differing results for measures of variability
and degrees of freedom. A domain analysis is an alternative procedure that allows the
user to analyze a portion of the population that they are interested in while accounting for
the complex survey data. With a domain analysis, results are produced for the full
sample, as well as for each subsample that are within the domain variable.
For this thesis, we decided to perform a sensitivity test to compare the results obtained
from a domain analysis with the results obtained from subsetting the data. For the
sensitivity test, we used the PROC SURVEYFREQ procedure and found that both
methods produced identical weighted frequencies however, the percentages and standard
errors were not equivalent. Given that we used SAS SURVEY procedures, it was decided
that performing a domain analysis would be most appropriate for all analyses (Lewis,
2013). For this thesis, one of the domains represented our analytic sample of interest. The
excess results produced from the other domain and full population sample were ignored.
For the descriptive statistics, the domain variable was included in the TABLES statement
to produce separate results that only included our analytic sample. Lastly, confidence
intervals were computed for all weighted, descriptive analyses.

3.5.2 Objective 3: differences in anxiety and depression from prepandemic to pandemic periods
To address objective 3, pre-pandemic anxiety and depression scores were first subtracted
from pandemic anxiety and depression scores to obtain a change score. Then, a paired ttest was used to determine if there was a significant mean difference in anxiety and
depression scores between the two time points. Specifically, the command PROC
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SURVEYMEANS was used to determine the mean difference values for the anxiety and
depression scores. The option “T” was specified to compute the t-values and p-values of
the two change scores. Weighted estimates were produced by including a WEIGHT
statement and a DOMAIN statement was also specified to compute separate estimates for
our subpopulation of interest. Assumptions for a paired t-test were met, including normal
distribution and independence (between subjects).

3.5.3 Objective 4: relationship between interruptions in genderaffirming medical care and pandemic anxiety levels
Initially, we were interested in analyzing ‘change’ in the two outcome variables.
However, in the literature, some researchers have raised concerns about using change
scores as outcomes in regression analyses. Shahar (2009) has argued that using a change
model does not estimate a causal effect between two time points. The author mentions
that a change model is actually quite similar to cross-sectional models and that it is only
superior in terms of having the ability to adjust for time-stable confounders. He also
demonstrates how subtracting two cross-sectional models yields a change model to
further emphasize that there is nothing conceptually different between the two (Shahar,
2009). As a result, it has been cautioned that change scores are simply a derived variable
and that they are not an effect of interest when exploring causal relationships (Shahar &
Shahar, 2012). Tennant et al. (2021) also have warned against the use of change scores.
Since the change score is a combination of two separate events, it merges the associated
causal pathways and potentially introduces inferential bias in observational studies. For
this reason, they also suggested using alternative statistical methods. Given the
conflicting literature on change models, we decided that for this thesis, it would be most
appropriate to use the follow-up (pandemic) anxiety and depression scores as the
outcomes in the regression models while adjusting for pre-pandemic anxiety and
depression levels.
To examine the relationship between interruptions in gender-affirming care and pandemic
anxiety, PROC SURVEYREG was used with both DOMAIN and WEIGHT statements.
Also, the imputed dataset was used for all regression analyses. There were three different
regression models that were assessed where different covariates and/or interactions were
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added to each model. For the first model, we fit a linear regression to look at the
relationship between interruptions in gender-affirming care and pandemic anxiety,
adjusting for pre-pandemic anxiety. For the second model, we used multiple linear
regression to examine the relationship between the exposure and pandemic anxiety,
adjusting for pre-pandemic anxiety and other potential confounders. In this model, we
also assessed for an interaction between interruptions in gender-affirming care and prepandemic anxiety levels because we suspected that one’s pre-pandemic anxiety score
might modify the relationship between interruptions in care and pandemic anxiety (e.g., if
an individual had a very high or low anxiety score pre-pandemic). If the interaction term
was not significant (p-value >0.05), it was excluded from the final model. The third
model used multiple linear regression to examine the relationship between the exposure
and pandemic anxiety adjusting for pre-pandemic anxiety and other potential confounders
that were determined from the DAG. This model was reported if the interaction term was
not significant in the previous model.

3.5.4 Objective 5: relationship between interruptions in genderaffirming medical care and pandemic depression levels
PROC SURVEYREG was used to conduct linear regression analyses for objective 5. A
domain analysis was performed in order to separately analyze our subpopulation of
interest and a WEIGHT statement was also included to produce weighted estimates. For
model 1, a linear regression model was fitted to assess the relationship between
interruptions in care and pandemic depression, adjusting for pre-pandemic depression.
For model 2, multiple linear regression was used to determine the association between
interruptions in care and pandemic depression while adjusting for pre-pandemic
depression and other potential confounders that were determined from the DAG. An
interaction term was also added to this model to assess whether pre-pandemic depression
might alter the relationship between interruptions in gender-affirming care and pandemic
depression. If the interaction term was significant (p-value <0.05), it was included in the
final model. The third model used multiple linear regression to examine the relationship
between the exposure and pandemic depression, adjusting for pre-pandemic depression
and other potential confounders. If the interaction was significant in the previous model,
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the main effects model (model 3) was not reported as it would be misspecified. Linear
regression assumptions were met, including linearity, homoscedasticity and independence
and normal distribution of residuals. Tolerance values were used to assess for potential
multicollinearity. No tolerance values were below 0.1, indicating no major concerns
regarding multicollinearity (O’Brien, 2007). Potential influential data points were also
examined using Cook’s D which indicated no issues with highly influential outliers.
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Chapter 4

4

Results

This chapter will present the descriptive characteristics of the total sample population as
well as for each of the interruptions in gender-affirming care groupings. It will also
describe interruptions in gender-affirming medical care during the COVID-19 pandemic
and it will present the results for the paired sample t-test analyses. Lastly, the results of
the regression models assessing the relationship between interruptions in genderaffirming care and pandemic anxiety and depression will be presented.

4.1 Objective 1: descriptive characteristics of the sample
This section will present the characteristics of the sample population as well as the
characteristics of TGNB individuals experiencing interruptions in gender-affirming
medical care during the COVID-19 pandemic.

4.1.1 Descriptive characteristics of the total sample population
Descriptive statistics for the total analytic sample (N=611) are presented in Table 2. The
sample sizes (N) are unweighted and the proportions and confidence intervals presented
are weighted. There were three age groups that participants predominantly belonged to,
which were the 20-24 age group (20.0%, 95% CI: 16.5, 23.5), 25-34 age group (34.2%,
95% CI: 30.2, 38.3), and 35-49 age group (24.3%, 95% CI: 20.7, 27.9). Gender identity
was relatively equally dispersed among three groups with 32.5% (95% CI: 28.4, 36.6)
identifying as woman/girl, 33.6% (95% CI: 29.4, 37.7) as man/boy and 32.1% (95% CI:
28.1, 36.0) as non-binary or similar. A small proportion identified as Indigenous or other
cultural identity (1.9%, 95% CI: 0.8, 2.9). The analytic sample had a higher proportion of
participants assigned female at birth (61.1%, 95% CI: 56.9, 65.4) compared to assigned
male at birth (38.9%, 95% CI: 34.6, 43.1). Study participants mainly lived in Ontario
(34.4%, 95% CI: 30.4, 38.4) and British Columbia (20.1%, 95% CI: 16.8, 23.4), with the
smallest proportion living in the territories (0.1%, 95% CI: 0.0, 0.3). Most individuals
lived in census metropolitan areas (93.5%, 95% CI: 91.2, 95.7) with 6.5% (95% CI: 4.3,
8.8) living in rural areas or small towns. Approximately 7.7% (95% CI: 5.1, 10.2) were
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Indigenous and 10.4% (95% CI: 7.8, 13.0) of individuals were racialized (perceived or
identified as a person of colour). A relatively small proportion of individuals were
immigrants to Canada (10.6%, 95% CI: 8.2, 13.1). Participants were generally well
educated with 39.8% (95% CI: 35.7, 44.0) having completed a college or university
degree with another 25.9% (95% CI: 22.1, 29.7) having completed some college,
university or Collège d'enseignement general et professionnel (CEGEP). For total
personal income (before taxes), about one fifth of respondents reported no personal
annual income (19.3%, 95% CI: 15.7, 22.8), with most reporting an income of less than
$15,000 (27.1%, 95% CI: 23.2, 31.0) and between the income bracket of $15,000 to
$29,999 (21.0%, 95% CI:17.5, 24.5).
Table 2
Characteristics of the participants in the analytic sample (N=611)
Characteristica
Age
15-19
20-24
25-34
35-49
50-64
65+
Gender
Woman or girl
Man or boy
Indigenous or other cultural identity
Non-binary or similar
Sex assigned at birth
Male
Female
Province/territory
British Columbia
Alberta
Saskatchewan
Manitoba
Ontario
Quebec
New Brunswick
Prince Edward Island
Nova Scotia
Newfoundland and Labrador
NWT/Nunavut/Yukon
Indigenous status
Indigenous
Not indigenous
Racializationb

Unweighted N

Weighted % (95% CI)

49
113
215
172
49
9

11.5 (8.4, 14.7)
20.0 (16.5, 23.5)
34.2 (30.2, 38.3)
24.3 (20.7, 27.9)
8.1 (5.8, 10.4)
1.8 (0.6, 3.0)

192
192
12
214

32.5 (28.4, 36.6)
33.6 (29.4, 37.7)
1.9 (0.8, 2.9)
32.1 (28.1, 36.0)

230
376

38.9 (34.6, 43.1)
61.1 (56.9, 65.4)

134
115
18
21
230
59
9
4
16
4
1

20.1 (16.8, 23.4)
19.2 (15.8, 22.6)
3.1 (1.5, 4.6)
3.0 (1.7, 4.3)
34.4 (30.4, 38.4)
15.0 (11.3, 18.8)
1.5 (0.5, 2.5)
0.5 (0.0, 1.0)
2.4 (1.2, 3.7)
0.7 (0.0, 1.5)
0.1 (0.0, 0.3)

38
571

7.7 (5.1, 10.2)
92.3 (89.8, 94.9)
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Racialized
66
Not racialized
543
Immigration history
Immigrant
75
Not an immigrant
536
Urban/rural
Living in a rural area/small town
36
Not living in a rural area/small town
574
Education
< High school
38
High school diploma
55
Some college or university or CEGEP
155
College or university degree
264
Grad/professional degree
99
Personal annual income in 2019
No personal annual income
106
< $15,000
163
$15,000 - $29,999
127
$30,000 - $49,999
83
$50,000 - $79,999
73
$80,000 +
48
a
Characteristics were reported from the 2020 survey data
b
This includes those who are perceived/treated or identify as people of colour

10.4 (7.8, 13.0)
89.6 (87.0, 92.2)
10.6 (8.2, 13.1)
89.4 (86.9, 91.8)
6.5 (4.3, 8.8)
93.5 (91.2, 95.7)
10.3 (7.1, 13.5)
11.7 (8.6, 14.7)
25.9 (22.1, 29.7)
39.8 (35.7, 44.0)
12.3 (9.8, 14.9)
19.3 (15.7, 22.8)
27.1 (23.2, 31.0)
21.0 (17.5, 24.5)
13.7 (10.7, 16.7)
10.8 (8.3, 13.4)
8.1 (5.7, 10.6)

4.1.2 Descriptive characteristics by interruptions in gender-affirming
care groupings
Table 3 represents the descriptive characteristics of participants by interruptions in
gender-affirming care groupings. Unweighted sample sizes (N) are presented with
weighted proportions and confidence intervals. Of the total analytic sample, there were
149 participants (Weighted %: 23.9%) who experienced interruptions in hormones
(including inability to get a new prescription or referral). Approximately half of these
individuals were between the ages of 25 to 49 (49.5%, 95% CI: 40.8, 58.2) with most of
them living in Ontario (36.2%, 95% CI: 28.0, 44.5), British Columbia (17.2%, 95% CI:
10.7, 23.6), or Alberta (19.1%, 95% CI: 12.3, 25.8). There were 7.0% (95% CI: 2.4, 11.7)
who also lived in a rural area or small town. Of those who experienced interruptions in
hormones, 39.1% (95% CI: 30.4, 47.7) identified as a man or boy, 29.9% (95% CI: 21.7,
38.0) identified as a woman or girl, and 29.5% (95% CI: 22.1, 37.0) as non-binary,
genderqueer or an identity similar; 1.5% (95% CI: 0.0, 3.3) identified as Indigenous or
another cultural identity. Most participants had received the gender-affirming medical
treatment that they needed/wanted (45.1%, 95% CI: 36.4, 53.8) or were in the process of
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completing gender-affirming medical treatment pre-pandemic (44.4%, 95% CI: 35.8,
53.0).
There were 23 participants (Weighted %: 3.3%) who experienced a surgical interruption
during the COVID-19 pandemic. This group largely consisted of individuals between the
ages of 25 to 49 (70.0%, 95% CI: 50.8, 89.2), and all were not living in a rural area or
small town (100%, 95% CI: 100.0, 100.0). Similar to those who experienced
interruptions in hormones, those who had surgical interruptions largely lived in British
Columbia (34.8%, 95% CI: 14.9, 54.7), Ontario (30.5%, 95% CI: 11.9, 49.1) or Alberta
(20.0%, 95% CI: 2.1, 37.9). There were 36.1% (95% CI: 15.7, 56.5) who identified as a
woman/girl, 38.6% (95% CI: 17.9, 59.3) who identified as a man or boy and 25.4% (95%
CI: 8.2, 42.6) who identified as non-binary, genderqueer or an identity similar. In terms
of pre-pandemic gender-affirming care status, most participants were in the process of
completing gender-affirming medical treatment (95.2%, 95% CI: 86.0, 100.0).
Interruptions in surgery and hormones was the smallest subgroup with 18 participants
(Weighted %: 2.5%) who had experienced an interruption in both treatments. More than
two-thirds of individuals were between the ages of 25 to 49 (70.2%, 95% CI: 48.2, 92.2).
Over half of the group identified as a man or boy (58.8%, 95% CI: 35.8, 81.8), 4.6%
(95% CI: 0.0, 13.5) identified as a woman or girl, 29.3% (95% CI: 8.7, 49.8) identified as
non-binary, genderqueer or a similar identity and 7.3% (95% CI: 0.0, 20.9) identified as
Indigenous or another cultural identity. Almost half of the subgroup resided in Ontario
(47.3%, 95% CI: 23.8, 70.8) with most of the other individuals living in either British
Columbia (16.8%, 95% CI: 0.0, 34.4) or Alberta (15.8%, 95% CI: 0.0, 32.5). There were
also 12.9% (95% CI: 0.0, 29.5) living in a rural area or small town. Most individuals in
this group were in the process of completing gender-affirming medical treatment (94.4%,
95% CI: 83.7, 100.0).
The final subgroup consisted of participants who did not experience interruptions in
gender-affirming medical care (N=421, Weighted %: 70.3%). There were 60.7% (95%
CI: 55.4, 66.0) of individuals in the 25 to 49 age group, 27.5% (95% CI: 22.5, 32.5) in the
14 to 24 age group and 11.7% (95% CI: 8.4, 15.1) in the 50+ age group. The proportion
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of participants who identified as woman or girl (34.2%, 95% CI: 29.2, 39.2), man or boy
(30.6%, 95% CI: 25.7, 35.5) and non-binary or similar (33.4%, 95% CI: 28.4, 38.3) was
relatively similar. Only 1.9% (95% CI: 0.5, 3.2) identified as Indigenous or another
cultural identity. Those who did not experience interruptions in care largely resided in
British Columbia (20.6%. 95% CI: 16.6, 24.6), Alberta (19.3%, 95% CI: 15.1, 23.4),
Ontario (33.5%, 95% CI: 28.7, 38.3), and Quebec (16.7%, 95% CI: 12.0, 21.4). Most
individuals in this group lived in census metropolitan areas (93.5%, 95% CI: 90.9, 96.2).
In terms of pre-pandemic gender-affirming care status, almost half the participants had
received the gender-affirming medical care that they needed or wanted (49.8%, 95% CI:
44.6, 55.1), while 37.7% (95% CI: 32.7, 42.7) were in the process and 12.5% (95% CI:
8.7, 16.4) were planning to receive gender-affirming care but had not begun.
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Table 3
Characteristics of TGNB individuals experiencing interruptions in gender-affirming medical care during the COVID-19 pandemic
stratified by type of interruption
Total
n=611

n

Weighted
%

Age
14-24

27.3,
35.7
54.2,
62.9
7.3,
12.5

162

31.5

387

58.6

58

9.9

192

32.5

192

33.6

12

1.8

28.4,
36.6
29.4,
37.7
0.8,
2.9

214

32.1

28.1,
36.0

134

20.1

115

19.2

18

3.1

25-49
50+
Gender Identity
Woman/girl
Man/boy
Indigenous/other
cultural identity
Non-binary,
genderqueer or
similar
Province/territory
BC

CI

AB
SK

16.8,
23.4
15.8,
22.6
1.5,
4.6

Interruptions in
hormonesa
n=149 (23.9%)b
Weighted
n
%
CI
36.6,
54.0
40.8,
58.2
1.6,
8.8

60

45.3

81

49.5

8

5.2

40

29.9

53

39.1

3

1.5

21.7,
38.0
30.4,
47.7
0.0
,3.3
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29.5

22.1,
37.0

27

17.2

29

19.1

5

2.5

10.7,
23.6
12.3,
25.8
0.3,
4.8

Interruptions in surgery
n=23 (3.3%)b
Weighted
%

n

5

21.2

16

70.0

2

8.8

8

36.1

8

Interruptions in
surgery and hormones
n=18 (2.5%)b
Weighted
n
%
CI

CI
4.1,
38.3
50.8,
89.2
0.0,
20.6

4

24.0

13

70.2

1

5.8

3.3,
44.8
48.2,
92.2
0.0,
16.8

1

4.6

38.6

15.7,
56.5
17.9,
59.3

10

58.8

0

0

-

1

7.3

0.0,
13.5
35.8,
81.8
0.0,
20.9

7

25.4

8.2,
42.6

6

29.3

8.7,
49.8

8

34.8

3

16.8

4

20.0

3

15.8

0.0,
34.4
0.0,
32.5

1

5.3

0

0

-

14.9,
54.7
2.1,
37.9
0.0,
15.3

No interruptions
n=421 (70.3%)b
Weighted
%

n

CI
22.5,
32.5
55.4,
66.0
8.4,
15.1

93

27.5

277

60.7

47

11.7

143

34.2

121

30.6

8

1.9

29.2,
39.2
25.7,
35.5
0.5,
3.2

149

33.4

28.4,
38.3

96

20.6

79

19.3

12

3.3

16.6,
24.6
15.1,
23.4
1.3,
5.2

54

MB

12

2.2

157

33.5

0.0,
21.9

44

16.7

6

1.5

4

0.7

12.5

0.0,
29.3

8

1.5

0

-

2

0.6

1
0.1
0
0
0
0
0
0
1
Urban/rural
Living in a rural
4.3,
2.4,
0.0,
area/small town
36
6.5
8.8
9
7.0 11.7
0
0
2
12.9
29.5
25
Not living in a
rural area/small
91.2,
88.3,
100.0,
70.5,
town
574
93.5 95.7
140
93.0 97.6
23
100.0 100.0 16
87.1 100.0 395
Pre-pandemic genderaffirming care (GAC)
status
Have had GAC
41.5,
36.4,
that I need/want
280
45.8 50.1
68
45.1 53.8
0
0
0
0
- 212
In the process of
38.3,
35.8,
86.0,
83.7,
completing GAC
275
42.6 46.8
67
44.4 53.0
22
95.2 100.0 17
94.4 100.0 169
Planning to
receive GAC (not
8.6,
5.1,
0.0,
0.0,
begun)
56
11.6 14.7
14
10.5 16.0
1
4.8
14.0
1
5.6
16.3
40
a
Includes those who had interruptions in taking hormones or those who were unable to get a new prescription or referral for hormones

0.2

0.9,
3.5
28.7,
38.3
12.0,
21.4
0.3,
2.7
0.0,
1.4
0.5,
2.6
0.0,
1.5
0.0,
0.5

6.5

3.8,
9.1

93.5

90.9,
96.2

21

3.0

230

34.4

59

15.0

9

1.5

4

0.5

16

2.4

4

0.7

ON
QC
NB
PEI
NS
NL
YT/NWT/NU

b

1.7,
4.3
30.4,
38.4
11.3,
18.8
0.5,
2.5
0.0,
1.0
1.2,
3.7
0.0,
1.5
0.0,
0.3

These are unweighted N’s with weighted proportions

8

5.3

56

36.2

14

13.0

2

1.0

0

0

6

4.5

2

1.2

1.6,
9.1
28.0,
44.5
6.2,
19.9
0.0,
2.5
0.9,
8.1
0.0,
3.0

1

4.8

8

30.5

1

4.6

0.0,
14.0
11.9,
49.1
0.0,
13.5

0

0

0

0

0

9

47.3

0

0

-

1

7.6

0

-

0

0

0

0

-

2

0

0

-

0

23.8,
70.8

37.7

44.6,
55.1
32.7,
42.7

12.5

8.7,
16.4

49.8
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4.2 Objective 2: describing interruptions in gender-affirming
medical care during the COVID-19 pandemic
Gender-affirming care status in 2020 and descriptive characteristics pertaining to
interruptions in care are presented in Table 4. Unweighted sample sizes (N) are presented
with weighted frequencies and confidence intervals. Most participants had received the
gender-affirming care that they needed/wanted (45.8%, 95% CI: 41.5, 50.1) or were in
the process of completing care (42.6%, 95% CI: 38.3, 46.8) in 2020. There were 500
participants who were taking hormones (91.6%, 95% CI: 89.3, 93.8) and 473 who had
access to hormones at the time of taking the survey (94.6%, 95% CI: 92.4, 96.7). Since
March 12, 2020, 26.9% (95% CI: 22.7, 31.1) of participants experienced interruptions in
hormones. The most frequently cited reasons for inability to access hormones were drug
shortages (52.4%, 95% CI: 43.3, 61.5), inability to get a prescription renewed (39.2%,
95% CI: 30.3, 48.2), and inability to go to the pharmacy (20.5%, 95% CI: 12.9, 28.0).
Since March 12, 2020, 14.3% (95% CI: 10.3, 18.2) of participants were unable to get a
new prescription or referral for hormones. Of these, approximately half reported that it
was due to restrictions related to COVID-19 (47.6%, 95% CI: 32.4, 62.8). 18.2% (95%
CI: 14.0, 22.5) of the sample had an appointment booked to have gender-affirming
surgery, of which approximately half had their appointment cancelled or postponed due
to COVID-19 (58.3%, 95% CI: 45.2, 71.4). The three most common surgeries that were
cancelled or postponed were chest surgery (50.9%, 95% CI: 34.6, 67.3), genital genderaffirming surgery (33.0%, 95% CI: 17.4, 48.5), and a hysterectomy or oophorectomy
(23.9%, 95% CI: 9.7, 38.1). Of those who had a surgical interruption, 37.5% (95% CI:
21.6, 53.5) had an alternative date set for the surgery and 19.9% (95% CI: 6.6, 33.2) had
the surgery since the initial cancellation. Participants had also experienced some
limitations in accessing additional aspects of gender-affirming health care due to
COVID-19, such as access to binders, packers or gaffs (14.3%, 95% CI: 9.9, 18.7), nonmedical supplies (14.4%, 95% CI: 10.7, 18.0), postoperative medical supplies (6.1%,
95% CI: 2.1, 10.2), and post-operative care following gender-affirming surgery (21.6%,
95% CI: 15.4, 27.8).
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Table 4
Gender-Affirming Care Status and Interruptions in Care due to COVID-19 (N=611)

Gender-Affirming Medical Care Characteristic
GAC status in 2020
Have had GAC that I need/want
In the process of completing GAC
Planning to receive GAC (not begun)
Taking hormones a
Yes
No
Access to hormones currently b
Yes
No
Interruptions in hormones since March 12, 2020 b
Yes
No
Reasons for inability to access hormones c
Couldn’t’ afford it
Couldn’t go to the pharmacy
Couldn’t get my prescription renewed
Couldn’t get syringes or needles
Drug shortages
Nobody to help with injections
People in my household couldn’t know I’m taking
hormones
Other
Unable to get a new prescription or referral for
hormones since March 12, 2020 d
Yes
No
Haven’t needed it during this time
Unable due to restrictions related to COVID-19 e
Yes
No
Before March 12 2020, had appointment booked to
have gender-affirming surgery d
Yes
No
Surgery appointment canceled/postponed due to
COVID-19 f
Yes
No
Not yet, but I expect it will
Alternative date set for surgery g
Yes
No
Type of surgery that was cancelled/postponed g

N

Weighted % (95% CI)
280
275
56

45.8 (41.5, 50.1)
42.6 (38.3, 46.8)
11.6 (8.6, 14.7)

500
55

91.6 (89.3, 93.8)
8.4 (6.2, 10.7)

473
27

94.6 (92.4, 96.7)
5.4 (3.3, 7.6)

139
361

26.9 (22.7, 31.1)
73.1 (68.9, 77.3)

12
27
53
13
77
11

8.8 (3.7, 13.9)
20.5 (12.9, 28.0)
39.2 (30.3, 48.2)
7.9 (3.5, 12.2)
52.4 (43.3, 61.5)
6.5 (2.6, 10.5)

2
11

1.0 (0.0, 2.4)
9.7 (3.7, 15.6)

48
210
71

14.3 (10.3,18.2)
62.2 (56.5, 67.9)
23.5 (18.3, 28.7)

24
24

47.6 (32.4, 62.8)
52.4 (37.2, 67.6)

67
264

18.2 (14.0, 22.5)
81.8 (77.5, 86.0)

41
14
12

58.3 (45.2, 71.4)
23.6 (11.8, 35.3)
18.1 (7.6, 28.6)

15
26

37.5 (21.6, 53.5)
62.5 (46.5, 78.4)
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Chest surgery
22
50.9 (34.6, 67.3)
Genital gender-affirming surgery
13
33.0 (17.4, 48.5)
Removal of uterus (hysterectomy) or removal of
ovaries (oophorectomy)
9
23.9 (9.7, 38.1)
Voice surgery
0
0
Adam’s apple surgery
2
4.9 (0.0, 11.8)
Facial surgery
1
2.4 (0.0, 7.3)
Other surgery
0
0
Had surgery since initial cancellation g
Yes
8
19.9 (6.6, 33.2)
No
33
80.1 (66.8, 93.4)
COVID-19 limited access to aspects of genderaffirming health care h
Binders, packers, or gaffs (n=293)
42
14.3 (9.9, 18.7)
Non-medical supplies (e.g., makeup, shaving
supplies, wigs) (n=413)
60
14.4 (10.7, 18.0)
Medical material that is important after surgery (e.g.
vaginal dilators, chest compress) (n=191)
10
6.1 (2.1, 10.2)
Post-operative care following gender-affirming
surgery(n=197)
45
21.6 (15.4, 27.8)
a
Only asked to those who have had the GAC they need/want or are in the process of completing GAC
(n=555)
b
Only asked to those who said they take hormones (n=500)
c
Asked to those who had interruptions in hormones since March 12, 2020 (n=139)
d
Asked to those who are in the process of completing GAC or are planning to receive GAC but have not
begun (n=331)
e
Only asked to those who were unable to get a new prescription or referral for hormones since March 12,
2020 (n=48)
f
Only asked to those who had an appointment booked to have gender-affirming surgery before March 12,
2020 (n=67)
g
Only asked to those who had a surgery appointment cancelled or postponed due to COVID-19 (n=41)
h
Asked amongst the participants for whom this was applicable to

4.3 Objective 3: paired sample t-test analyses for anxiety
and depression
Pre-pandemic and pandemic anxiety and depression statistics are presented in Table 5.
The OASIS was used to measure self-reported anxiety levels with a possible score range
of 0 to 20. The CES-D-10 was used to measure self-reported depression levels (possible
score range of 0 to 30). The average pre-pandemic anxiety score was 10.17 (SD=4.12),
and the average pre-pandemic depression score was 14.30 (SD=6.74). In terms of
pandemic scores, the average anxiety and depression scores were 10.38 (SD=3.98) and
16.41 (SD=6.56), respectively. We also looked at the prevalence of those who were likely
experiencing clinical depression during both the pre-pandemic and pandemic periods, and
it was determined that 71.1% and 83.1% of our sample was experiencing depressive
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symptoms that are consistent with clinical depression, respectively. In regards to prepandemic and pandemic anxiety prevalence, 76.7% and 77.6% of respondents had a
probable anxiety disorder, respectively.
Table 5
Pre-pandemic and pandemic anxiety and depression statistics

Mean

Standard
Deviation

Standard
Error of the
Mean

95% CI for Mean
Lower

Upper

Pre-pandemic anxiety

10.17

4.12

0.20

9.77

10.57

Pandemic anxiety

10.38

3.98

0.19

10.02

10.74

Pre-pandemic depression

14.30

6.74

0.31

13.70

14.91

Pandemic depression

16.41

6.56

0.30

15.83

17.00

In Table 6, a paired sample t-test is presented which was used to evaluate whether there
was a significant difference in anxiety scores from pre-pandemic anxiety to pandemic
anxiety. On average, the pandemic anxiety scores were 0.29 points (SD= 3.20, 95% CI: 0.02, 0.61) higher than the pre-pandemic anxiety scores. However, this difference was
not statistically significant (t= 1.84, p= 0.0657) and it is concluded that there is no
evidence from unadjusted analysis to suggest that TGNB persons are experiencing
greater levels of pandemic anxiety compared to pre-pandemic anxiety.

A paired sample t-test was also used to assess if there was a difference in depression
scores from pre-pandemic depression to pandemic depression and this is displayed in
Table 6. On average, the pandemic depression scores were 2.23 points (SD= 5.95, 95%
CI: 1.69, 2.76) higher than the pre-pandemic depression scores. There is evidence to
suggest that depression scores changed from pre-pandemic to pandemic (t= 8.15, p
<0.0001) and that on average, TGNB persons are experiencing greater depressive
symptomology since the onset of the pandemic.
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Table 6
Paired t-test assessing the difference in anxiety and depression scores from pre-pandemic
to pandemic periods

Paired Differences
95% Confidence
Interval of the
Difference

Mean

Standard
Deviation

Standard
Error of
the Mean

Lower

Upper

t Value

P-value

Post-pre
anxiety

0.29

3.20

0.16

-0.02

0.61

1.84

0.0657

Post-pre
depression

2.23

5.95

0.27

1.69

2.76

8.15

<0.0001

4.4 Objective 4: regression analyses of interruptions in
gender-affirming care and anxiety
4.4.1 Model 1— interruptions in gender-affirming medical care as a
predictor of pandemic anxiety (adjusting for pre-pandemic
anxiety)
The linear regression analysis between the exposure, interruptions in gender-affirming
care and the outcome, pandemic anxiety, is presented in Table 7 as Model A. Compared
to the reference group—those who did not have interruptions in gender-affirming care—
interruptions in taking hormones was not significantly associated with pandemic anxiety
after adjusting for pre-pandemic anxiety (β=0.59, p=0.0577). Additionally, compared to
the reference group, there was also no statistically significant association between
surgical interruptions (β=-0.43, p=0.4684) or interruptions in taking hormones and
surgical interruptions (β=1.49, p=0.0539) and pandemic anxiety after adjusting for prepandemic anxiety. The R2 value was 0.4747; therefore, interruptions in gender-affirming
care and pre-pandemic anxiety explained 47.47% of the variation in pandemic anxiety.
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4.4.2 Model 2— interruptions in gender-affirming medical care as a
predictor of pandemic anxiety, assessing for an interaction
between interruptions in care and pre-pandemic anxiety
levels and adjusting for other potential confounders
The second model involved conducting a multiple linear regression to assess whether
there was a significant association between the exposure and outcome after adjusting for
confounders and with the addition of an interaction between pre-pandemic anxiety and
interruptions in care. The confounders that were adjusted for include: income changes
due to COVID-19, current geographic location, current social support, educational
attainment, COVID-19 related health concerns, low-income household, pre-pandemic
anxiety and depression, and pre-pandemic gender-affirming care status. This model
yielded similar results to the first model; after controlling for the covariates, all three
interruption categories—interruptions in taking hormones (β=1.62, p=0.1102), surgical
interruptions (β=-0.96, p=0.5546) and interruptions in taking hormones and surgical
interruptions (β=0.52, p=0.8493)—were not significantly associated with pandemic
anxiety when compared to the reference group no interruptions in care. There also was no
statistically significant interaction observed between interruptions in care and prepandemic anxiety. Therefore, the interaction was removed from the final multiple linear
regression model (Model 3).

4.4.3 Model 3— interruptions in gender-affirming medical care as a
predictor of pandemic anxiety, adjusting for pre-pandemic
anxiety and other potential confounders
A multiple linear regression was conducted with interruptions in care, pandemic anxiety
and potential confounders which included income changes due to COVID-19, current
geographic location, current social support, educational attainment, COVID-19 related
health concerns, low-income household, pre-pandemic anxiety and depression and prepandemic gender-affirming care status. The results are reported in Table 7 as Model B.
Similar to the first model, after adjusting for additional confounders, the results revealed
that there were no observed associations between interruptions in taking hormones
(β=0.50, p=0.0892), surgical interruptions (β=-0.95, p= 0.1124) or interruptions in both
hormones and surgery (β=1.28, p=0.0826) with pandemic anxiety when compared to the
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reference group. The model fit was improved from the first model with more variance
being explained with the addition of the independent variables (R2=0.5489).
Table 7
Anxiety regression models (N=611)
Model Aa

Variable
β

Standard

t

estimate

error

Value

No

Model Bb
p value

R2

β

Standard

t

estimate

error

Value

Reference group

R2

p value

Reference group

interruptions
Interruptions
in taking
hormones

0.59

0.31

1.90

0.0577

-0.43

0.59

-0.73

1.49

0.77

0.64

0.04

0.4747

0.50

0.30

1.70

0.0892

0.4684

-0.95

0.60

-1.59

0.1124

1.93

0.0539

1.28

0.74

1.74

0.0826

16.96

<0.0001

0.54

0.05

11.00

<0.0001

0.5489

Surgical
interruptions
Interruptions
in taking
hormones and
surgical
interruptions
Pre-pandemic
anxiety
a

Adjusting for pre-pandemic anxiety

b

Adjusting for the following minimum sufficient set of confounders: income changes due to COVID-19,

current geographic location, current social support, educational attainment, COVID-19 related health
concerns, low-income household, pre-pandemic anxiety and depression, pre-pandemic gender-affirming
care status
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4.5 Objective 5: regression analyses of interruptions in
gender-affirming care and depression
4.5.1 Model 1— interruptions in gender-affirming medical care as a
predictor of pandemic depression (adjusting for prepandemic depression)
The results for this model are presented in Table 8 as Model C. The 2019 depressionadjusted association between interruptions in care and pandemic depression is reported
with the interaction term for comparison, as the interaction was significant in further,
adjusted models. There were no significant associations between having a surgical
interruption or having both a surgical and hormonal interruption with pandemic
depression. However, participants who experienced an interruption in taking hormones
with a pre-pandemic depression score of 0, had on average a 3.77-point increase in
pandemic depression score compared to those who had no interruptions in care (β= 3.77,
p=0.0270).
For every one-unit increase in pre-pandemic depression score, the pandemic depression
score decreased by 0.16 points for individuals who experienced hormonal interruptions
compared to those who had no interruptions (β =-0.16, p=0.1087). This interaction was
not significant in this model, however, values at different levels of pre-pandemic
depression are presented for interpretability. For those who experienced an interruption in
taking hormones with a pre-pandemic depression score of 14.30 (the sample mean), there
was a 1.48-point increase in pandemic depression score compared to those who had no
interruptions in care. For TGNB persons who experienced interruptions in hormonal care
and had a pre-pandemic depression score of 21.04 (mean + 1SD), there was a 0.40-point
increase in pandemic depression relative to those who had no interruptions. Lastly, for
participants who had a hormonal interruption and a pre-pandemic depression score of
7.56 (mean – 1SD), there was a 2.56-point increase in pandemic depression compared to
individuals who had no interruptions. The model fit was moderate with an R2 value of
0.3644.
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4.5.2 Model 2—— interruptions in gender-affirming medical care as a
predictor of pandemic depression, assessing for an
interaction between interruptions in care and pre-pandemic
depression and adjusting for other potential confounders
The confounder-adjusted results are presented in Table 8 as Model D. The minimum
sufficient set of confounders that were adjusted for included income changes due to
COVID-19, current geographic location, current social support, educational attainment,
COVID-19 related health concerns, low-income household, pre-pandemic anxiety and
depression and pre-pandemic gender-affirming care status. Consistent with the first
model, in comparison to those who had no interruptions in care, there were no significant
associations between having a surgical interruption or having both a surgical and
hormonal interruption with pandemic depression after adjusting for additional
confounders. However, after adjustment, participants who experienced an interruption in
taking hormones with a pre-pandemic depression score of 0 had on average a 3.54-point
increase in pandemic depression score compared to those who had no interruptions in
care (β= 3.54, p=0.0115). After adjustment, for every one-unit increase in pre-pandemic
depression score, the pandemic depression score decreased by 0.16 points for those who
experienced hormonal interruptions compared to those who had no interruptions (β =0.16, p=0.0344). After adjusting for additional confounders in this model, the interaction
became significant.
For TGNB persons who experienced interruptions in hormones and had a pre-pandemic
depression score of 14.30 (the sample mean), there was a 1.25-point increase in pandemic
depression compared to those who had no interruptions, after adjustment of confounders.
For individuals who had hormonal interruptions and a pre-pandemic depression score of
21.04 (mean + 1SD), there was a 0.17-point increase in pandemic depression score
relative to persons who had no interruptions, after adjustment. Lastly, compared to those
who had no interruptions, individuals who experienced an interruption in hormones with
a pre-pandemic score of 7.56 (mean – 1SD), had a 2.33-point increase in pandemic
depression after adjusting for confounders. With the additional covariates, the model fit
was improved in this model as the independent variables explained more variation in the
dependent variable (R2 = 0.4900).
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Table 8
Depression regression models (N=611)
Model Ca

Variable
β

Standard

t

estimate

error

Value

No

Model Db
p value

R2

β

Standard

t

estimate

error

Value

Reference group

R2

p value

Reference group

interruptions
Interruptions
in taking
hormones

3.77

1.71

2.21

0.0270

3.34

3.00

1.11

2.22

3.23

0.59

0.3644

3.54

1.40

2.53

0.0115

0.2662

2.69

2.75

0.98

0.3285

0.69

0.4916

0.96

2.38

0.40

0.6864

0.07

8.40

<0.0001

0.46

0.05

8.75

<0.0001

-0.16

0.10

-1.61

0.1087

-0.16

0.08

-2.12

0.0344

-0.33

0.23

-1.43

0.1541

-0.33

0.21

-1.60

0.1096

-0.02

0.16

-0.12

0.9061

0.02

0.11

0.20

0.8387

0.4900

Surgical
interruptions
Interruptions
in taking
hormones and
surgical
interruptions
Pre-pandemic
depression
Interruptions
in taking
hormones x
pre-pandemic
depression
Surgical
interruptions x
pre-pandemic
depression
Interruptions
in taking
hormones and
surgical
interruptions x
pre-pandemic
depression
No

Reference group

Reference group

interruptions x
pre-pandemic
depression
a

Adjusting for pre-pandemic depression

b

Adjusting for the following minimum sufficient set of confounders: income changes due to COVID-19,

current geographic location, current social support, educational attainment, COVID-19 related health
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concerns, low-income household, pre-pandemic anxiety and depression, pre-pandemic gender-affirming
care status

4.5.3 Model 3— interruptions in gender-affirming medical care as a
predictor of pandemic depression, adjusting for prepandemic depression and other potential confounders
After testing for an interaction in Model 2, we concluded that one of the interactions was
indeed significant, therefore, the main effects model (Model 3) would be misspecified.
As a result, this multiple linear regression model was not conducted since the interaction
term was significant in the previous model.
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Chapter 5

5

Discussion

This chapter will discuss the findings of both the descriptive and regression analyses
while also discussing how our results integrate with the previous literature on COVID-19
and transgender health. It will also discuss the strengths and limitation of the current
study along with recommendations for future research.

5.1 Summary of results
5.1.1 Changes in anxiety and depression symptoms from prepandemic to pandemic periods
For depression, a cut-point of ten or higher indicates the presence of significant
depressive symptoms (Andresen et al., 1994). It is important to note that CES-D-10
measures depressive symptoms that are consistent with clinical depression and that this
cut-point might not indicate a clinical diagnosis of depression in and of itself. In our
study sample, the average pre-pandemic and pandemic depression scores were well above
the cut-point of ten. Moreover, there was also a high proportion of individuals crossing
this cut-point for both time periods, with an even greater prevalence of probable clinical
depression during the pandemic period. This suggests that on average, TGNB persons in
our study are experiencing high levels of depressive symptomology that may be
consistent with clinical depression. However, it is also important to note that this
established cut-point might not map onto clinical depression the same way within TGNB
communities. Although this scale is increasingly being used in this population, it is
important to note that there are no prior studies that have assessed whether these
measurement properties hold in the TGNB population. Therefore, even though a high
proportion might cross this threshold, it might not indicate that all these individuals are
indeed clinically depressed. Our findings that our sample presented with relatively high
levels of depression symptoms is consistent with previous literature (Rotondi, Bauer,
Travers, et al., 2011; Rotondi, Bauer, Scanlon, et al., 2011; Veale, Peter, Travers et al.,
2017; Pitts et al., 2009).
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For anxiety, a cut-point of eight or higher is indicative of a probable anxiety disorder
(Campbell-Sills et al., 2009). In our study sample, the average pre-pandemic and
pandemic anxiety scores were both above the cut-point of eight. Moreover, we
determined that there was a high prevalence of individuals crossing this cut-point value
both prior and during the pandemic. This suggests that on average, TGNB persons in our
study are experiencing anxiety severity that could be classified as an anxiety diagnosis.
Our findings are consistent with previous literature that has found that anxiety levels are
heightened in TGNB populations (Jaffray, 2020; Smith et al., 2014; McNeil et al., 2012).
Overall, this study supports previous findings that TGNB persons are experiencing a
disproportionally high level of anxiety and depression.
Our paired sample t-test analyses revealed that on average, TGNB persons in our sample
were not experiencing greater levels of pandemic anxiety compared to pre-pandemic
anxiety. However, there is evidence indicating that TGNB individuals were experiencing
greater pandemic depressive symptomology compared to pre-pandemic; pandemic
depression scores were significantly higher by an average of 2.23 points. This is an
interesting finding as we had hypothesized that both anxiety and depression levels would
be heightened amidst the pandemic. Aligned with our study findings, a U.S. based
longitudinal cohort study reported that on average, psychological distress was higher
during the pandemic compared to pre-pandemic (Kidd et al., 2021). Another study of 161
TGNB youth in the U.K. revealed that several youths qualitatively reported that their
anxiety and depressive symptoms were exacerbated during the pandemic; however, some
youth also reported that their mental health improved during the pandemic due to having
more free time to work on their mental well-being, as well as having reduced social
anxiety (Jones et al., 2021). Therefore, although some pandemic-related changes could
have increased anxiety levels, it is also possible that some TGNB persons in our sample
were not as anxious in other aspects of their lives (e.g., social) during the pandemic; this
could explain why anxiety levels did not fluctuate much. The PRIDE longitudinal study
reported that among the 2288 SGM persons included in their study, depression and
anxiety symptoms increased from pre-pandemic to post-pandemic (Flentje et al., 2020).
However, they also mentioned that among those who screened positive for anxiety prepandemic, there was no significant change in anxiety. Considering that on average, our
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sample also consisted of participants with a probable anxiety disorder pre-pandemic and
there was no significant change in anxiety score, it is possible that the pandemic
measures did not alter anxiety levels for some TGNB persons who were already
experiencing anxiety symptoms consistent with a probable anxiety disorder prepandemic.
Previous literature has demonstrated that negative or stressful life events are associated
with increases in anxious arousal—defined as symptoms of hyperarousal that are specific
to anxiety—and anxiety sensitivity (McLaughlin & Hatzenbuehler, 2009; Wardenaar et
al., 2014). Specifically, McLaughlin & Hatzenbuehler (2009) mentioned that stressful life
events, in particular events that are related to health, were associated with heightened
anxiety sensitivity. Given that pandemic-related changes—such as interruptions in
gender-affirming care—could have resulted in stressful experiences for TGNB persons,
we would have expected changes in anxiety severity from the pre-pandemic to pandemic
periods.

5.1.2 Descriptive characteristics of the sample population
In the total sample population, over half the sample was within the age groups of 25-34
and 35-49 years, a greater proportion were assigned female at birth, and participants
largely lived in Ontario, British Columbia or Alberta, and were from census metropolitan
areas. Considering that these are more of the heavily populated provinces in Canada, it is
not surprising that most participants were living in these regions. Indigenous persons
account for 4.9% of the general Canadian population (Statistics Canada, 2017a); in
comparison, the proportion of Indigenous persons in our study was slightly higher
(7.7%). Although most participants were educated, many did not have a personal annual
income or were in a lower income bracket. Annual income is largely dependent on an
individuals’ employment, and the literature has suggested that sexual and gender
minorities, including TGNB persons, are often susceptible to workplace discrimination
(Geoffroy & Chamberland, 2015). As a result, this might make it increasingly difficult
for TGNB persons to find employment or to be promoted to higher positions in their
workplace. Additionally, the Trans PULSE Ontario project reported other barriers to
employment for TGNB persons such as, inability to get academic transcripts and
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references letters that reflect the correct name and gender; some transgender Ontarians
had also reported declining job offers due to the potential of working in an unsupportive
environment (Bauer et al., 2011). However, it is also important to note that our sample
included many youths which might also explain why there were participants who did not
have a personal annual income. A worldwide cross-sectional study that investigated
COVID-19 impacts on transgender healthcare also had some similar demographics to our
study (Koehler et al., 2020). For example, this study had a greater proportion of
participants assigned female at birth and participants were also generally highly educated
with almost half the sample having received a college or university degree (Koehler et al.,
2020). It is not surprising that TGNB persons in our study were generally very educated,
considering that Canadians in general are very educated; over 50% of Canadians between
the ages of 25 and 64 have completed college or university education (Statistics Canada,
2017b).

5.1.3 Descriptive characteristics by interruptions in gender-affirming
care groupings
For objective 1, we also described age, gender identity, province/territory, urban/rural
area of residence, and pre-pandemic gender-affirming care status characteristics by
interruptions in care groupings. The first group, interruptions in hormones, was the most
frequently reported interruption in our sample. There is evidence that other populations,
such as the elderly with chronic diseases, were also experiencing interruptions in
medications during the pandemic (Hsiao et al., 2020). One of the reasons cited was that
elderly persons feared getting infected with COVID-19 when picking up their
prescription; it is possible that some participants in our sample were also experiencing
hormonal interruptions for this reason. In 2019, most had reported having received the
gender-affirming care they need/want or were in the process of completing genderaffirming care. It is important to note that even though participants received the genderaffirming care they needed in 2019, they were still able to experience an interruption in
hormones during the pandemic; it is common for TGNB persons to remain on hormone
therapy for their lifetime to prevent unwanted changes to secondary sex characteristics.
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The second group, interruptions in surgeries, had a relatively small proportion of
individuals within it. Most persons were in the process of completing gender-affirming
care in 2019 with none having reported that they had received the gender-affirming care
that they needed/wanted. It is plausible that most were in the process of completing
gender-affirming care in 2019 because they were likely waiting or attempting to schedule
their gender-affirming surgery during that time. Moreover, among those who experienced
surgery interruptions, it is possible that there was a high proportion of individuals in the
25 to 49 age group because youth are unable to schedule a surgery appointment until they
reach a certain age (usually 18 years), and younger adults may still be deciding whether
gender-affirming surgery is the right choice for them before starting the process to access
a surgery. The third group, interruptions in surgery and hormones, had the smallest
number of participants. Similar to the surgical interruptions group, the interruptions in
surgery and hormones group also mainly consisted of participants aged 25 to 49, and
most participants were in the process of completing gender-affirming care in 2019; which
is expected for the same reasons that were mentioned previously.

5.1.4 Interruptions in gender-affirming care during the COVID-19
pandemic
In 2020, participants in our sample largely reported having received the gender-affirming
care they needed or that they were in the process of completing gender-affirming care.
Among those who had the gender-affirming they needed or were in the process of
completing care, approximately 90% reported that they were taking hormones with close
to 95% having reported that they had access to hormones at the time of taking the survey.
However, approximately a quarter of those individuals who were taking hormones
reported a hormonal interruption since March 12, 2020. Given that this survey was
administered in October of 2020 and the pandemic was declared in March of 2020, this
might suggest that those who had experienced interruptions in hormones during the first
few months of the pandemic were no longer experiencing those interruptions by October
of 2020. This was before the second wave fully hit in Canada, and so the epidemiological
situation was likely more favourable with a greater resumption of activities and less
restrictions across the country. As a result, this might explain why less people reported
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not having current access to hormones at the time of the survey. However, even with
taking this into consideration, we still saw an effect of interruptions in hormones on
pandemic depression.
The TransCare Covid-19 project—a worldwide cross-sectional survey that predominantly
consisted of participants from European countries—revealed similar results; of those who
were accessing hormonal care, 21.8% reported that their current access was restricted
(Koehler et al., 2020). The most frequently cited reasons for inability to access hormones
in our study were drug shortages, inability to get prescriptions renewed and inability to
go to the pharmacy. In contrast to our study, Koehler et al. (2020) reported that the
inability to get an appointment with a hormone prescriber was the primary reason for
hormone restrictions, whereas our sample reported drug shortages as the main factor for
hormonal interruptions. Of those who were taking hormones in our study, approximately
half the participants cited drug shortages as the reason behind their hormonal
interruptions (52.4%), whereas 26.2% of the participants in the TransCare Covid-19
project reported that they had restricted access due to reasons related to hormonal supply.
It is important to mention that drug shortages were noted in Canada before the onset of
the pandemic; for example, shortages in injectable drugs, including testosterone, have
been recognized prior to the pandemic (PHSA, n.d.). Therefore, drug shortages for
TGNB people could have existed prior to COVID-19. Given that Health Canada has
reported that there are drug shortages in relation to COVID-19 (Health Canada, 2021), it
is also possible that the pandemic further exacerbated drug shortages for TGNB persons.
Another global study that largely consisted of participants from the European and SouthEast Asia regions reported that about a third of their sample had reduced access in
hormones which is relatively similar to our study findings (Jarrett et al., 2021). A U.S.
study of 208 TGNB persons found that 32.7% of participants experienced delays in
receiving or starting gender-affirming hormones (Kidd et al., 2021); this is also similar to
our study findings as almost one third of participants had a hormonal interruption or were
unable to get a new prescription/referral for hormones. Therefore, hormonal interruptions
commonly occurred in multiple countries all over the globe; this is not surprising since
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most countries implemented similar pandemic measures, such as stay-at-home orders,
which resulted in service disruptions during the pandemic.
Of those who were in the process or were planning to receive gender-affirming care,
almost one fifth of participants had an appointment booked to have gender-affirming
surgery prior to the pandemic. Approximately half of these participants had their surgery
appointment cancelled or postponed due to COVID-19. This was similar to other
healthcare treatments in Canada; Chen-See (2020) reported that over 50% of those
receiving cancer care had their appointments cancelled or rescheduled due to COVID-19.
In our study, about one third of participants had an alternative date set for the surgery
with about one fifth having had the surgery since the initial cancellation. These results are
not surprising considering that surgeries deemed as “non-essential” were largely
cancelled across Canada; in fact, from March to June 2020, there were approximately 335
000 fewer surgeries performed in Canada in comparison to the previous year (CIHI,
2020). Evidently, this has created a massive backlog of elective surgeries that need to be
rescheduled for a later date (Samson, 2021).
The most commonly reported surgery cancellation in our study was chest surgery,
followed by genital gender-affirming surgery and hysterectomy or oophorectomy.
Previous literature has suggested that top surgeries are much more common compared to
bottom surgeries among TGNB populations (Nolan et al., 2019). Therefore, it is not
surprising that within our sample, the cancellation of chest surgeries was most common
as more participants likely had a chest surgery scheduled relative to other genderaffirming surgeries.
The predominantly European TransCare Covid-19 project reported that among
participants who already had an appointment, 15.6% experienced a surgery cancellation
or postponement with 19.5% expecting to have a surgery cancellation (Koehler et al.,
2020). Similarly, in our study, 18.1% of participants who had an appointment booked to
have surgery expected to have a surgery cancellation in the future. Surprisingly, the
proportion of TGNB persons in Canada who experienced surgical interruptions was over
three times higher compared to the TransCare Covid-19 study. This could suggest that in
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general, non-elective surgeries, including gender-affirming surgeries, were cancelled at a
much higher rate in Canada compared to European countries. A U.S. based study with a
longitudinal cohort of TGNB persons also revealed that 11.1% of their sample had
reported a gender-affirming surgery cancellation or postponement (Kidd et al., 2021).
Overall, these findings are expected because surgeries deemed non-urgent or elective,
including gender-affirming surgeries, were largely cancelled across the globe amidst the
pandemic (WHO, 2020a).
Apart from hormonal and surgical interruptions, TGNB persons in our sample also
reported limited access to other aspects of gender-affirming health care (e.g., access to
binders, packers or gaffs, non-medical supplies including makeup and wigs, medical
materials that are important after surgery). It is possible that some individuals may have
had reduced access to some of these aspects of care because of the closure of nonessential stores during peak periods of the pandemic. The TransCare Covid-19 project
reported relatively similar findings to our study, with 12.4% of TGNB persons in their
sample reporting restricted access to binders and packing material, and 16.3% had
restricted access to non-medical supplies (Koehler et al., 2020). A global study, that
predominantly had participants from Europe and Southeast Asia, reported that among
those who were using gender-affirming care services before the onset of the pandemic,
31.1% had reductions in surgical aftercare materials, 36.6% had reductions in cosmetic
supplies and services, with 33.3% reporting a reduction in access to body modifiers,
including binders and packing materials (Restar et al., 2021). This means that reductions
in cosmetic supplies and services and body modifiers was double that of what was
reported in our sample for those aspects of gender-affirming healthcare. Moreover,
reductions in surgical aftercare were also much higher in the global study compared to
our study (31.1% vs. 6.1%).
It is possible that income loss was higher in some European and South-East Asian
countries compared to Canada, which in turn may have reduced access to some aspects of
gender-affirming healthcare. For example, the study by Restar et al. (2021) reported that
due to the pandemic, almost three fourths of their sample anticipated a reduced income.
In Canada, CERB was quickly provided to financially support individuals who were
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impacted by the COVID-19 pandemic, with other forms of financial support that were
provided as the pandemic progressed (Government of Canada, 2021); financial support to
this extent may not have been provided in other countries across the globe. Therefore, the
financial aid provided by the Canadian government might have mitigated the impact of
the pandemic on financial loss and in turn, reduced its effect on access to certain aspects
of gender-affirming health care.

5.1.5 Regression analyses of interruptions in gender-affirming care
and anxiety
Three different regression models were used to assess whether that was an association
between interruptions in gender-affirming care and pandemic anxiety. The first model,
which included interruptions in gender-affirming care as a predictor of pandemic anxiety
(adjusting for pre-pandemic anxiety), revealed that there was no significant relationship
between interruptions in gender-affirming care and pandemic anxiety. The R2 value was
relatively high (R2= 0.4747) indicating that 47.47% of the variation in pandemic anxiety
was explained by the independent variables. The second model adjusted for confounders
and included an interaction term as it was suspected that pre-pandemic anxiety levels
might modify the relationship between the exposure and outcome. The third and final
model assessed for an association between interruptions in gender-affirming care and
pandemic anxiety with adjustment of confounders. After adjustment, it was determined
that there still was no significant association between interruptions in gender-affirming
care and pandemic anxiety. This was surprising given that previous literature has
determined positive associations between receiving gender-affirming care and improved
mental health (Almazan & Keuroghlian, 2021; Baker et al., 2021; Wernick et al., 2019;
White Hughto & Reisner, 2016; Passos et al., 2020). Considering that individuals who
seek gender-affirming care are likely experiencing heightened mental health challenges,
such as increased anxiety severity related to gender dysphoria, we hypothesized that
interruptions would likely affect anxiety levels during the pandemic; however, this was
not a finding in our study. Moreover, the R2 value increased slightly from the first model
to the third model (R2=0.5489 vs R2=0.4747), indicating that collectively, the additional
independent variables that were added to the third model improved model fit slightly. It
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would be interesting to assess how much variation in pandemic anxiety is predicted just
by pre-pandemic anxiety levels, which was not investigated in our study.
Similar to our findings, a U.S. longitudinal cohort study of TGNB individuals did not
find a significant relationship between interruptions in gender-affirming care and greater
pandemic psychological distress, after adjusting for pre-pandemic psychological distress.
The authors in this study suggested that it is possible that there was no significant
association because pre-pandemic psychological distress might be a stronger predictor of
heightened psychological distress during the pandemic (Kidd et al., 2020). Therefore, it is
possible that in our study, pre-pandemic anxiety was also a stronger predictor of
pandemic anxiety levels. In contrast to our study, a global cross-sectional study revealed
that there was a relationship between screening positive for anxiety and reduced access to
at least one or more gender-affirming resources (Jarrett et al., 2021). It is possible that the
investigators in this study found a significant relationship simply because they were
unable to control for pre-pandemic anxiety levels. It is also possible that participants in
their sample experienced multiple sources of reduced access to gender-affirming care
(which were included when examining this relationship), whereas our study solely looked
at hormonal and surgical interruptions to assess this relationship.

5.1.6 Regression analyses of interruptions in gender-affirming care
and depression
In the final model for the depression outcome, variables encoding interruptions in taking
hormones, pre-pandemic depression, and their interaction all remained statistically
significant after confounders were controlled. This is not surprising considering there is
previous research that has demonstrated the improvements in mental health outcomes
upon receiving gender-affirming care (Almazan & Keuroghlian, 2021; Baker et al., 2021;
Wernick et al., 2019; White Hughto & Reisner, 2016; Passos et al., 2020). Hormonal
interruptions could lead to an unwanted change in secondary sex characteristics and
therefore heighten gender dysphoria.
The interaction term between interruptions in taking hormones and pre-pandemic
depression became statistically significant in the adjusted model; therefore, the
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association between interruptions in hormones and pandemic depression was modified by
pre-pandemic depression. Every unit increase in pre-pandemic depression score resulted
in the pandemic depression score decreasing by 0.16 points for individuals who
experienced hormonal interruptions. The effect of interruptions in hormonal care on
pandemic depression was greater for those who had lower pre-pandemic depression
levels. In comparison, the effect of hormonal interruptions was smaller for those who had
higher pre-pandemic depression scores. This might be the case because for those who
already had high pre-pandemic depression levels, their pandemic depression scores could
only increase to a certain extent since their score was already high. Contrary to our
hypothesis, after adjustment for confounders, all variables representing the association of
surgical interruptions or both surgical and hormonal interruptions, pre-pandemic
depression, and their interaction remained insignificant. It is possible that there was no
relationship between having a surgical interruption and pandemic depression because
TGNB persons were much more understanding of their surgery appointments being
postponed as the country was in a state of emergency, and there was a potential of
extreme hospital overcrowding with COVID-19 patients. The R2 value increased for the
final multiple linear regression model, demonstrating that the model fit improved with the
addition of the covariates (R2 = 0.4900).
A global cross-sectional study determined that there was a relationship between screening
positive for depression and reduced access to gender-affirming resources due to the
pandemic (Jarrett et al., 2021); this aligns with our study findings. In contrast, our
findings were different from the U.S. longitudinal study conducted by Kidd et al. (2021);
they did not find a significant relationship between interruptions in gender-affirming care
and greater psychological distress after adjusting for pre-pandemic mental health levels.
Considering that the sample size for their study was much smaller, it is possible that they
did not have adequate power to detect a significant association (Kidd et al., 2021); this
might explain why their results vary from the findings in this study.

5.2 Strengths and limitations
Researchers have called for more studies to longitudinally examine how impacts of the
COVID-19 pandemic have affected TGNB mental health (Restar et al., 2021). One
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strength of this study is that we were able to longitudinally examine associations, since
data were collected both before and after the onset of the pandemic. This allowed us to
establish causal inferences when examining whether interruptions in gender-affirming
care were associated with changes in anxiety and depression levels. To our knowledge,
there are only a few studies that have collected data on anxiety and depression both prepandemic and during the pandemic among TGNB persons. Most were instead crosssectional study designs, making it difficult to establish any causal inferences in terms of
mental health changes. Also, the sample used data from the Trans PULSE Canada study
which is the first of its kind to collect data on TGNB health and wellbeing across age
groups and provinces/territories in Canada. To our knowledge, Canada does not have a
major dataset that has addressed the experiences of LGBTQ2+ Canadians during the
pandemic, which may be because data on sexual orientation and gender identity are
lacking in COVID-19 research efforts. As a result, this study is the first national study
that has examined whether interruptions in gender-affirming care due to COVID-19 was
associated with changes in anxiety and depression among TGNB Canadians. This study
also described how the pandemic impacted transgender-specific healthcare across
Canada, which has not yet been reported in other studies. Another advantage is that our
study included a relatively large number of participants who identified as non-binary,
genderqueer, agender or a similar identity which has previously been recognized as an
understudied population (Motmans et al., 2019). Lastly, our study included individuals
aged 15 and older which increases the generalizability of our results to many different
age groups.
It is important to note that there are limitations present in this study. First, the participants
in this sample were generally highly educated, which was expected considering the
Canadian population is one of the most educated populations in the world (Statistics
Canada, 2017b). As such, it is possible that less educated persons in the community
might not be represented in this sample and thus, the COVID-19 impacts reported in this
study might underestimate what was truly experienced for those individuals. Given the
relationship between intersectionality and structural inequality, TGNB persons who also
belong to other minority or marginalized groups, including racial and ethnic minority
groups, might be disproportionately affected by COVID-19 (Bowleg, 2020). Due to the
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small proportion of participants who identified or were perceived as people of colour in
our TGNB sample, our results may not be generalizable to individuals who belong to
more than one marginalized group and experience multiple sources of oppression. Most
of our respondents also lived in densely populated provinces (e.g., Ontario) and urban
areas; therefore, the findings might be more reflective of persons living in those areas.
The Trans PULSE Canada team recontacted 1184 participants to complete the 2020
questionnaire and had a total of 826 survey respondents. After the removal of six
observations, the final sample size for the 2020 COVID-19 survey was 820. Although the
retention rate was relatively high and weights were used to try and reduce biases related
to survey completion, there is a possibility that differential attrition could have impacted
the study results if individuals who were most impacted by the pandemic were the least
likely to complete the 2020 questionnaire (Kidd et al., 2021). Conversely, there is also a
possibility that those who were heavily impacted by the pandemic were more likely to
complete as the 2020 COVID-19 questionnaire was more relevant to them. Additionally,
the data collected were self-reported which might influence participants to respond to
questions in a manner that is more socially desirable. For example, there is often stigma
surrounding the topic of mental health and as such participants might choose to
underreport their anxiety and depression symptoms.
Another limitation was the small sample size for certain interruption in gender-affirming
care groups. Specifically, there were only 23 and 18 participants in the interruptions in
surgery and interruptions in surgery and hormones groups, respectively. Although these
groups are quite small, they were not grouped together because they were qualitatively
different. We hypothesized that hormonal interruptions would have more of an effect on
depression and anxiety than surgical interruptions. Surgery interruptions were happening
across the country for various populations, as such TGNB persons might be more
understanding of this type of delay as there was a global hospital crisis. In contrast,
interruptions in hormones will affect TGNB persons’ wellbeing almost immediately. On
the other hand, surgical interruptions were likely to last longer than hormonal
interruptions and this could also have an influence on anxiety and depression levels.
Therefore, there was no a priori knowledge to suggest that interruptions in surgery and
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hormones should be grouped with the surgical interruption group instead of the hormonal
interruption group. Nevertheless, the results should be interpreted with caution because
the small sample sizes in these two groups likely resulted in reduced power, which might
have affected the ability to determine a significant association. The small sample sizes
could also affect the reliability or precision in our regression estimates.
Our study was conducted in the fall of 2020 however the COVID-19 pandemic was
declared in March (2020). It is possible that by the time the questionnaire was
administered, hormonal interruptions could have already been resolved. From the data
that were collected, it was not possible to know how long or the exact time period that
participants experienced certain interruptions. Instead of asking respondents about their
mental health during the specific time periods that they may have had interruptions,
anxiety and depression levels were measured at the time of taking the questionnaire.
Therefore, it is possible that pandemic anxiety and depression levels reported were not
reflective of the mental health levels when the actual interruption in care had been
experienced. Another limitation in our study is that participants may have misinterpreted
the question pertaining to interruptions in hormones in which those who had “intentional
interruptions” may have been included, whereas the focus of this study was only on those
who had “unintentional interruptions.” However, we tried to reduce this as much as
possible by going through the “other” reasons for inability to access hormones and recoding obvious intentional interruptions (e.g., choosing to discontinue or trying to
conceive) as no interruptions in hormones.
Residual confounding may have also been present in our study. A DAG was used to
determine the minimum sufficient set of confounders to adjust for in order to measure an
unbiased association between our exposure and outcomes. Previous literature and a priori
knowledge were used for guidance in creating the DAG. Given the limited research
available on this novel topic, it is possible that additional, unidentified confounding
factors may not have been considered. Also, the survey data that were used to measure
the confounding variables may not have been measured precisely; this could lead to
residual differences between interruptions in care groups which could ultimately bias the
results (Dekkers et al., 2019).
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5.3 Future research
This study was able to describe the COVID-19 pandemic impact on access to genderaffirming healthcare, while also examining how interruptions in hormones and surgeries
affected anxiety and depression in Canada. Future studies should focus on assessing the
relationship between disruptions in post-operative care after recent gender-affirming
surgeries and mental health, as complications with surgery aftercare might have a
detrimental impact on TGNB health and well-being. Our study found that there was no
relationship between interruptions in care and pandemic anxiety; it would be interesting
to qualitatively explore why the pandemic might have improved or had a reduced impact
on anxiety in TGNB populations. It would also be useful to investigate what interventions
might mitigate the impact of the pandemic on TGNB access to gender-affirming
healthcare in case of a future resurgence in COVID-19 cases and further restrictions.
Future research should also focus on examining whether the changes in depressive
symptoms observed in this study were long-term or resolved. Mental health should
continue to be monitored throughout and after the pandemic to be able to determine
whether there are long-term effects of the pandemic on the mental health of TGNB
persons.
For groups with small sample sizes, it is difficult to quantitatively analyze intersections.
Therefore, oversampling small groups might be beneficial to create intersections that are
large enough for analysis; this would allow researchers to investigate the pandemic
effects on individuals with intersecting identities. With a better understanding of how the
pandemic has affected these individuals, new interventions and policies can be
established to help reduce inequalities that might be present for persons that belong to
more than one marginalized group. Also, most COVID-19 data that are available for
TGNB persons were collected via online questionnaires; future studies should focus on
potentially incorporating multimode research in order to reach very low-income or less
educated TGNB people in Canada. Moreover, more research needs to be conducted
globally to have a better understanding on how the pandemic may have affected or
continues to affect access to gender-affirming healthcare during the pandemic. With
many services offered online due to COVID-19, exploring TGNB individuals’ experience
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with virtual, mental health services would provide practical feedback to mental health
service providers, which might improve virtual healthcare that is provided to this
community in the future.
Overall, TGNB communities experience high levels of anxiety and depression, and
interruptions in gender-affirming care may have increased depressive symptoms in an
already highly-depressed group. This is very concerning considering the relationship
between anxiety and depression and suicide risk. It is important to investigate whether
pandemic-related interruptions and changes have resulted in higher suicidal ideation and
behaviour, along with self-harm risks in order to implement necessary interventions that
could help at-risk populations, including the TGNB community. Moreover, with the rapid
emergence of different variants, it is possible that the pandemic may not be coming to an
end anytime soon. As a result, it is important for policy makers to ensure that the impact
of pandemic-related changes, including interruptions in gender-affirming care for TGNB
persons, are only temporary and that they need to be urgently resolved.
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About you

Welcome to the survey! These first questions are meant to give you a chance to tell us some basic
information about yourself.

1.

How old are you?
__________ years old

2.

Which of the following reflect your ethno-racial background? (Please check all that
apply)

❑
❑
❑
❑
❑
❑
❑
❑
❑
❑
❑
❑
❑
❑

Black African (e.g. Ghana, Kenya, Somalia)
Black Canadian or African-American
Black Caribbean (e.g., Jamaica, Haiti)
East Asian (e.g. China, Japan, Korea, Taiwan)
Indigenous (e.g. First Nations, Metis, Inuit, Native American)
Indo-Caribbean (e.g. Guyanese with origins in India)
Jewish
Latin American (e.g. Argentina, Mexico, Nicaragua)
Middle Eastern (e.g. Egypt, Iran, Israel, Saudi Arabia)
South Asian (e.g. India, Sri Lanka, Pakistan)
South East Asian (e.g. Vietnam, Malaysia, Philippines)
White Canadian or White American
White European (e.g. England, Greece, Sweden, Russia)
Other, please specify: _________________________________

Please answer the next question only if you selected “Indigenous” above. Otherwise, please
skip to #3.

2a.

Are you…? (Please check all that apply)
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3.

❑

Unsure

Yes
No

Do you identify as a person of colour?



5.

First Nations (status)
First Nations (non-status)
Métis
Inuk
Indigenous from Canada, don’t know which group
Indigenous from another country

Are you perceived or treated as a person of colour in Canada?



4.

❑
❑
❑
❑
❑
❑

Yes
No

What country were you born in?

 Canada → Skip to #7
 Outside of Canada, please specify country: ___________________________
 Unsure
6.

How long have you been living in Canada?
________ years and _______ months

7.

What province or territory do you currently live in?












Alberta
British Columbia
Manitoba
New Brunswick
Newfoundland and Labrador
Nova Scotia
Ontario
Prince Edward Island
Quebec
Saskatchewan
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8.

Northwest Territories
Nunavut
Yukon

Have you been living in your current province/territory since March 12, 2020?



9.

Yes
No

What is the postal code where you live or get mail?

 My postal code is: __ __ __ __ __ __
 I don’t know my postal code
 I would rather not share my full postal code. The first three digits are: __ __ __
10.

What is the highest level of formal education you have completed?













11.

Some high school, no diploma or GED
GED
High school graduate
Some CÉGEP, no diploma
CÉGEP graduate
Some college or trade school, no degree
College or trade school graduate
Some university, no degree
Bachelor’s degree
Some graduate work, no degree
Master’s degree (e.g. MA, MS, MBA)
Doctoral or professional degree (e.g. PhD, MD, JD)

Are you currently enrolled as a student?




12.

Yes, full-time
Yes, part-time
No

What is your sexual orientation? (Please check all that apply)

❑
❑
❑
❑
❑

Asexual
Bisexual
Gay
Lesbian
Pansexual
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❑
❑
❑
❑
❑

Queer
Straight or Heterosexual
Two-Spirit
Not sure or questioning
Other, please specify: _________________________________

The next questions are about sex and gender. The response categories might not be a perfect fit
for you, which is why we also want to know how you self-identify!

13.

What term(s) do you use to describe your gender?
___________________________________________

14.

What sex were you assigned at birth, meaning on your original birth certificate?



15.

Male
Female

If you had to select ONE response that best describes your current gender identity for the
purposes of a survey, what would it be?






Man or boy
Woman or girl
Indigenous or other cultural gender identity (e.g., two-spirit)
Non-binary, genderqueer, agender, or a similar identity

Income

If you are not yet 16 years old, please skip to #25 on page 6.
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In the next sections, we’ll ask about experiences you may have had in the past 12 months (since
today’s date in September 2019), and since March 12, 2020 - the day after the World Health
Organization declared COVID-19 to be a pandemic. We need to ask about both of these
timeframes to compare to how you answered the same questions in 2019, and to understand what
has changed since the pandemic.

Next we are going to ask a few questions about your income, including how your income has
been affected in recent months. Although a lot of health costs are covered by health insurance,
there is still a relationship between our health and our incomes. Please know that, like all other
information you have provided, these answers will be kept confidential.
We recognize that, as a community, we work in all types of fields. When we talk about work and
income, we are talking about all types of income-generating activity, both formal and informal
employment. This includes work from public speaking to sex work to child care.

16.

What is your best estimate of the total income from all members living in your household
including yourself, before taxes and deductions, from all sources in in 2019? (Include any
money your household received from any person or organization.) By household
members, we mean people with whom you share income and resources, or who share
income and resources with you.













17.

Less than $10,000
$10,000 to less than $15,000
$15,000 to less than $20,000
$20,000 to less than $30,000
$30,000 to less than $40,000
$40,000 to less than $50,000
$50,000 to less than $60,000
$60,000 to less than $80,000
$80,000 to less than $100,000
$100,000 to less than $150,000
$150,000 or more
Unsure

Including yourself, how many people (in or outside of Canada) were being supported on
this income?
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________ people

18.

What is your best estimate of your total personal income, before taxes and other
deductions from all sources in 2019? (include any money you received from any person
or organization)















19.

Public social assistance or welfare
Public disability support
Both public social assistance/welfare and disability support
I did not receive income from either of these sources

Since March 12, 2020 did you receive any income from the following sources?






21.

Unsure

Before March 12, 2020, were you receiving any income from the following sources?






20.

I didn’t have a personal income
Less than $10,000
$10,000 to less than $15,000
$15,000 to less than $20,000
$20,000 to less than $30,000
$30,000 to less than $40,000
$40,000 to less than $50,000
$50,000 to less than $60,000
$60,000 to less than $80,000
$80,000 to less than $100,000
$100,000 to less than $150,000
$150,000 or more

Public social assistance or welfare
Public disability support
Both public social assistance/welfare and disability support
I did not receive income from either of these sources

Since March 12, 2020, did you receive any of the following types of Employment
Insurance benefits? (Please check all that apply)
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❑
❑
❑
❑
❑
❑
❑
❑
22.

Regular
Sickness
Caregiving or compassionate care
Work-sharing
Other Employment Insurance benefit
Canada Emergency Response Benefit (CERB)
Canada Emergency Student Benefit (CESB)
Did not receive any benefits

Since March 12, 2020, how much income have you received from government funded
COVID-19 relief programs (including rent relief)?
$________

❑
23.

I did not receive any relief

Which of the following best describes the impact of COVID-19 on your ability to meet
financial obligations or essential needs, such as rent or mortgage payments, utilities and
groceries?









24.

Major negative impact
Moderate negative impact
Minor negative impact
No impact
Minor positive impact
Moderate positive impact
Major positive impact
Too soon to tell

Which of the following best describes the impact of COVID-19 on your ability to make
rent or mortgage payments?









Major negative impact
Moderate negative impact
Minor negative impact
No impact
Minor positive impact
Moderate positive impact
Major positive impact
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25.

Too soon to tell

Which of the following statements best describes the food eaten in your household since
September 2019?




You and your household always had enough of the kinds of food you wanted to eat
You and your household had enough to eat, but not always the kinds of food you
wanted
Sometimes you and your household did not have enough to eat
Often you and your household didn’t have enough to eat



26.

Which of the following statements best describes the food eaten in your household since
March 12, 2020?




You and your household always had enough of the kinds of food you wanted to eat
You and your household had enough to eat, but not always the kinds of food you
wanted
Sometimes you and your household did not have enough to eat
Often you and your household didn’t have enough to eat




If you are not yet 16 years old, please skip to the Indigenous Well-Being section (#36 on page
9) if you are Indigenous, or the Your Health section (#39 on page 10) if you are nonIndigenous.

Employment
27.

Before March 12, 2020, which of the following best described your personal employment
situation? (Please check all that apply)

❑
❑
❑
❑
❑
❑

Employed in a permanent full-time position (30 hours or more per week)
Employed in a permanent part-time position (less than 30 hours per week)
Employed on temporary/short term contract (less than a year)
Employed on a fixed term contract, one year or more
Self-employed – no employees
Self-employed – others work for me
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❑
❑
❑
❑
❑
❑
❑
28.

Worked for pay in the informal economy (e.g. paid in cash or “under the table” in
restaurant or construction)
Not employed
Student
Retired
On leave
Other, specify: _________________________________
None of the above

Which of the following best describes your current personal employment situation?
(Please check all that apply)

❑
❑
❑
❑
❑
❑
❑
❑
❑
❑
❑
❑
❑
29.

Employed in a permanent full-time position (30 hours or more per week)
Employed in a permanent part-time position (less than 30 hours per week)
Employed on temporary/short term contract (less than a year)
Employed on a fixed term contract, one year or more
Self-employed – no employees
Self-employed – others work for me
Work for pay in the informal economy (e.g. paid in cash or “under the table” in
restaurant or construction)
Not employed
Student
Retired
On leave
Other, specify: _________________________________
None of the above

As a result of the COVID-19 pandemic, has your employment situation changed in any of

the following ways? (Please check all that apply)

❑
❑
❑
❑
❑
❑
❑
❑
❑
❑

Still working, but working less (e.g., lost one of my jobs, reduced hours)
Not working, I have lost my job or jobs
Temporarily laid-off
Start date has been delayed
Lost a job that I was supposed to start in the future
No longer have employment prospects
Currently looking for work
No longer looking for work
Working more
No change
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30.

How much of an impact did the COVID-19 pandemic have on your personal income
from employment?









31.

Major negative impact
Moderate negative impact
Minor negative impact
No impact
Minor positive impact
Moderate positive impact
Major positive impact
Too soon to tell

Since March 12, 2020, has there been a time when you experienced a total loss of
personal income from employment?



32.

Yes
No

Since September 2019, have you done sex work or exchanged sex for money or other
resources (e.g. shelter, substances, food, or other services)?



32a.



32b.



33.

Yes
No → Skip to #33
Have you done sex work since March 12, 2020?
Yes
No → Skip to #33
Have you seen sex work clients in person since March 12, 2020?
Yes
No

Do you currently have regular face-to-face contact with the public at your work?




Yes
No
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34.

Are you an essential service worker (healthcare, grocery store staff, etc.)?




34a.





35.

I’m not working currently

Yes
No → Skip to #35
Unsure
Which of the following sectors best captures your job?
Health care or public health
Grocery store
Food service
Other, please specify: __________________________________

Since March 12, 2020, have you started a new job because of COVID-19?




Yes
No

Indigenous Well-Being
If you are not Indigenous, please skip to the Your Health section on page 10.

The next few questions are about ways that Indigenous trans, two-spirit, non-binary, and gender
diverse people are staying healthy during the pandemic. These questions were developed by the
team’s Indigenous Leadership Group.

36.

Are you a part of an Indigenous community? This could be online or in person.

 Yes
 No → Skip to #37
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36a. Since March 12, 2020, has your access to Indigenous community gatherings
(online or in person)…

 Increased
 Stayed the same
 Decreased
37.

Can you describe any ways you are staying connected to Indigenous community
or culture during the pandemic?

38.

Before March 12, 2020, did you participate in ceremony?

 Yes
 No → Skip to #39
38a.

Has your participation changed as a result of COVID-19?

 Yes
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 No → Skip to #39
38b.

How has this change impacted your physical, mental, emotional, or
spiritual well-being?

Your Health

The next few questions are about your health right now.

39.

In general, would you say your health is…?





Excellent
Very good
Good
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40.

Do you have a compromised immune system?



41.

Fair
Poor

Yes
No

Do you have diabetes or a chronic condition affecting your lungs, heart or kidneys?




Yes
No

The next few questions are about disabilities. We acknowledge that disability is a very broad
category that can include many realities and experiences. Some people who might be labelled
under disability categories might not identify as living with a disability.
*Note: Episodic disabilities are long-term conditions that are characterized by periods of good
health interrupted by periods of illness or disability). These may include, but are not limited to
asthma, arthritis, and HIV.

42.

Do you self-identify as someone who currently lives with the following realities or
conditions? (Please check all that apply)

❑
❑
❑
❑
❑
❑
❑
❑
❑
❑

Autistic
Blind
Crip
Deaf
Disabled or living with a disability (including episodic disability*)
Chronic pain
Chronic illness
Chronic health condition
Neurodivergent
Psychiatric survivor, mad, or person with mental illness
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❑
❑
43.

Another disability identity not listed here: _______________________
None of the above

Have you been diagnosed with any of the following? (Please check all that apply)

❑
❑
❑
❑
❑
❑
❑
❑
❑
❑
❑

Acquired brain injury
Autism or Asperger’s
Chronic Illness
Chronic pain condition
Intellectual or developmental disability
Intermittent or episodic illness or condition
Learning disability
Mobility or physical disability
Vision impairment
Mental health condition
Another condition or disability not listed here :
________________________________

❑

None of the above

COVID-19 Testing, Diagnosis, and Care

In the next few questions, we would like to ask you about symptoms, testing, and treatment of
COVID-19.
44.

When a COVID-19 vaccine becomes available, how likely is it that you will choose to
get it?






45.
apply)

Very likely → Skip to #46
Somewhat likely
Somewhat unlikely
Very unlikely
Unsure

What are the reasons you would not get the COVID-19 vaccine? (Please check all that
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❑
❑
❑
❑
❑
❑
❑
❑
❑
❑
46.

Already had or think I have had COVID-19
Do not consider it necessary to get the vaccine
Not confident in the safety of the vaccine
Do not believe in vaccination
Concern about risks and side effects
Have a pre-existing medical condition
Will wait until it seems safe to get the vaccine
Have not yet decided
Other reason, please specify: ________________________________
Unsure

Have you wanted to get tested for COVID-19, but been unable to?




Yes
No → Skip to #47

46a.

❑
❑
❑
❑
❑
❑
❑
❑
❑

In what month(s) did this happen? (Please check all that apply)

January
February
March
April
May
June
July
August
September

46b.

Why were you unable to get tested?
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47.

Have you avoided COVID-19 testing or care when you thought you needed it?




Yes
No → Skip to #48

47a.

Have you avoided COVID-19 testing or care because of fear of discrimination as
a trans or non-binary person?




Yes
No

47b.

Can you describe why you avoided COVID-19 testing or care?
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48.

Have you been tested for COVID-19 with a swab since March 12, 2020?




49.

Yes
No → Skip to #50

48a.

In what month(s) were you tested? (Please check all that apply)

❑
❑
❑
❑
❑
❑
❑

March
April
May
June
July
August
September

Have you been diagnosed with COVID-19?




Yes
No → Skip to #50

49a.








50.

In what month were you diagnosed?

March
April
May
June
July
August
September

Regardless of whether you have been diagnosed with COVID-19, do you think you have
had COVID-19 symptoms?




51.

Yes → Skip to #52
No
Unsure

If you develop symptoms of COVID-19, do you think you will avoid testing for fear of
mistreatment?
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52.

Yes → Skip to #53
No → Skip to #53
Unsure → Skip to #53

How severe are/were your symptoms and how did you manage them?








No symptoms → Skip to #53
Mild, no significant symptoms
Significant symptoms self-managed in quarantine
Significant symptoms managed with medical assistance in quarantine
Symptoms requiring hospital treatment for ≤ 1 day
Symptoms requiring hospital treatment for > 1 day

52a.









In what month did you start having COVID-19 symptoms?

March
April
May
June
July
August
September

52b.

How long did your symptoms last?

________ weeks and ________ days
52c.




Are you still having symptoms now?
Yes
No

If you have not been tested for COVID-19, or if you have not wanted to be tested for COVID19, please skip to #54.
53.

When looking for COVID-19 testing or care, have you experienced discrimination?




Yes
No → Skip to #54
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53a.



53b.

Did this happen because you’re trans or non-binary?
Yes
No
Can you describe the discrimination that you experienced?

Your Mental Health

The next questions are about how you’re doing in terms of mental health and well-being,
including some questions about suicide and self-harm.

If you need to speak to someone immediately about your mental health, please contact Canada’s
Trans Life Line (call 877-330-6366), the Indigenous Hope for Wellness Help Line (call 1-855242-3310), Crisis Services Canada (call 1-833-456-4566 or text 45645 [call 1-866-277-3553 in
Quebec]), or Kids Help Phone (call 1-800-668-6868 or text CONNECT to 686868).

54.

In general, would you say your mental health is…?
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55.

Excellent
Very good
Good
Fair
Poor

Compared to before physical distancing began, how would you say your mental health is
now?






56.

Much better now
Somewhat better now
About the same
Somewhat worse now
Much worse now

Below is a list of the ways you might have felt or behaved. Please tell us how often you
have felt this way during the past week.

56a. I was bothered by things that usually don’t bother me.

Occasionally or a
Rarely or none of the

Some or a little of the

moderate amount of

Most or all of the time

time (less than 1 day)

time (1-2 days)

time (3-4 days)

(5-7 days)
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56b. I had trouble keeping my mind on what I was doing.
Occasionally or a
Rarely or none of the

Some or a little of the

moderate amount of

Most or all of the time

time (less than 1 day)

time (1-2 days)

time (3-4 days)

(5-7 days)









56c. I felt depressed.
Occasionally or a
Rarely or none of the

Some or a little of the

moderate amount of

Most or all of the time

time (less than 1 day)

time (1-2 days)

time (3-4 days)

(5-7 days)









56d. I felt that everything I did was an effort.
Occasionally or a
Rarely or none of the

Some or a little of the

moderate amount of

Most or all of the time

time (less than 1 day)

time (1-2 days)

time (3-4 days)

(5-7 days)









56e. I felt hopeful about the future.
Occasionally or a
Rarely or none of the

Some or a little of the

moderate amount of

Most or all of the time

time (less than 1 day)

time (1-2 days)

time (3-4 days)

(5-7 days)
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56f. I felt fearful.
Occasionally or a
Rarely or none of the

Some or a little of the

moderate amount of

Most or all of the time

time (less than 1 day)

time (1-2 days)

time (3-4 days)

(5-7 days)









56g. My sleep was restless.
Occasionally or a
Rarely or none of the

Some or a little of the

moderate amount of

Most or all of the time

time (less than 1 day)

time (1-2 days)

time (3-4 days)

(5-7 days)









56h. I was happy.
Occasionally or a
Rarely or none of the

Some or a little of the

moderate amount of

Most or all of the time

time (less than 1 day)

time (1-2 days)

time (3-4 days)

(5-7 days)









56i. I felt lonely
Occasionally or a
Rarely or none of the

Some or a little of the

moderate amount of

Most or all of the time

time (less than 1 day)

time (1-2 days)

time (3-4 days)

(5-7 days)
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56j. I could not get “going.”
Occasionally or a
Rarely or none of the

Some or a little of the

moderate amount of

Most or all of the time

time (less than 1 day)

time (1-2 days)

time (3-4 days)

(5-7 days)









57.

The following items ask about anxiety and fear. For each item, please select the answer
that best describes your experience over the past week.
57a.






57b.






57c.

How often do you feel anxious?
Never
Rarely
Occasionally
Frequently
Constantly
When you feel anxious, how intense or severe is your anxiety?
I never feel anxious
Mild
Moderate
Severe
Extreme
How often do you avoid situations, places, objects, or activities because of

anxiety or fear?






57d.

Never
Rarely
Occasionally
Frequently
Constantly
How much does anxiety or fear interfere with your ability to do the things you
need to do at work, at school, or at home?




Not at all
Mild
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57e.

Moderate
Severe
Extreme

How much does anxiety or fear interfere with your social life and relationships?







Not at all
Mild
Moderate
Severe
Extreme

The next questions are about suicide and self-harm.
If you need to speak to someone immediately about your mental health, please contact Canada’s
Trans Life Line (call 877-330-6366), the Indigenous Hope for Wellness Help Line (call 1-855242-3310), Crisis Services Canada (call 1-833-456-4566 or text 45645 [call 1-866-277-3553 in
Quebec]), or Kids Help Phone (call 1-800-668-6868 or text CONNECT to 686868).
58.

Since September 2019, have you done anything to hurt yourself on purpose? For
example, cutting, burning, scratching, or hitting yourself.




Yes
No → Skip to #59

58a.



59.

Has this happened since March 12, 2020?
Yes
No

Since September 2019, have you seriously considered suicide?




Yes
No → Skip to #60

59a.




Yes
No

Have you seriously considered suicide since March 12, 2020?
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60.

Since September 2019, have you attempted suicide?




Yes
No → Skip to #61

60a.




Since March 12, 2020, have you attempted suicide?

Yes
No → Skip to #61

If you need to speak to someone immediately about your mental health, please contact Canada’s
Trans Life Line (call 877-330-6366), the Indigenous Hope for Wellness Help Line (call 1-855242-3310), Crisis Services Canada (call 1-833-456-4566 or text 45645 [call 1-866-277-3553 in
Quebec]), or Kids Help Phone (call 1-800-668-6868 or text CONNECT to 686868).

61.

Before March 12, 2020, were you receiving mental health support from a community
support worker or a support group (in person, over the phone, or online)?



62.

Yes
No

Since March 12, 2020, have you received mental health support from a community
support worker or a support group (in person, over the phone, or online)?



63.

Yes
No

Before March 12, 2020, were you talking to a therapist or mental health care professional
regularly (in person, over the phone, or online)?



64.

Yes
No

Since March 12, 2020, have you talked to a therapist or mental health care professional
(in person, over the phone, or online)?



Yes
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65.

No

Since March 12, 2020, have you not received mental health care that you thought you
needed?





Yes
No → Skip to #66
I have not needed mental health care during this time → Skip to #66

65a. Can you explain why you didn’t receive this?

Next, we’d like to ask you about cigarettes, vaping, and cannabis.

66.

At the present time, do you smoke cigarettes daily, occasionally or not at all?




67.

At the present time, do you vape nicotine / e-cigarettes daily, occasionally or not at all?




68.

Daily
Occasionally
Not at all

Daily
Occasionally
Not at all

At the present time, do you use cannabis daily, occasionally or not at all?



Daily
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Occasionally
Not at all

The next few questions ask about your alcohol consumption.
When we use the word ‘drink’ it means:
- one (1) bottle or can of beer or a glass of draft
- one (1) glass of wine or a wine cooler
- one (1) drink or cocktail with 1½ ounces of liquor

69.

How often did you have a drink containing alcohol in the past year?






70.

How many drinks did you have on a typical day when you were drinking in the past year?






71.

Never → Skip to #72
Monthly or less
2 to 4 times a month
2 to 3 times a week
4 or more times a week

1 to 2
3 to 4
5 to 6
7 to 9
10 or more

How often did you have 6 or more drinks on one occasion over the past year?







Never
Less than monthly
Monthly
Weekly
Daily or almost daily
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72.

In the following question, please indicate which substances you have used since
September 2019, and whether you used that substance several times a week or more. If
you have not used a substance, then you don’t have to answer the second question for that
substance.



I have not used any of the listed substances

Since September

Since September

2019, have you

2019, have you

used this

used this several

substance?

times a week or
more?

Heroin and other street opioids




Yes →
No




Yes
No




Yes →
No




Yes
No






Yes →
No
Yes →
No






Yes
No
Yes
No




Yes →
No




Yes
No




Yes →
No




Yes
No




Yes →
No




Yes
No

(e.g., fentanyl, “down”)
Prescription opioids not prescribed to you
(e.g., codeine, methadone, oxycodone,
morphine, fentanyl, hydromorphone,
tramadol, buprenorphine)
Cocaine powder or crack
Ritalin, or another prescription stimulant not
prescribed to you (e.g. Concerta, Dexedrine,
Adderall, or Vyvanse)
Methamphetamine (ice, crystal meth, tina) or
other amphetamines (speed)
Sedatives or sleeping pills
(e.g., zopiclone or benzodiazepines such as
Xanax, Valium, Serapax, clonazepam)
Inhalants, glue, solvents
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Synthetic cannabinoids (e.g., K2, Spice)
Ecstasy (MDA, MDMA)
Hallucinogens








Yes →
No
Yes →
No
Yes →
No








Yes
No
Yes
No
Yes
No








Yes →
No
Yes →
No
Yes →
No








Yes
No
Yes
No
Yes
No

(e.g., LSD, acid, mushrooms, PCP)
Ketamine (Special K)
GHB (G)
Other, please
specify:______________________

Health Care

In the next few questions, we would like to learn about your experiences with finding competent
and respectful health care and social services.

73.

Do you currently have insurance that covers all or part of the cost of your prescription
medications?




74.

Yes
No
Unsure

Since September 2019, was there ever a time when you felt that you needed health care,
other than home care services, but didn’t receive it?




Yes
No → Skip to #75
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74a.



75.

Has this happened since March 12, 2020?

Yes
No

Before March 12, 2020, were you receiving home care?




Yes
No → Skip to #76

75a.

Since March 12, 2020, have you experienced interruptions or changes to the
home care services you were receiving?




Yes
No → Skip to #76

75b.

Can you describe the service change or interruptions you experienced, and how
this affected you?
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Virtual and Tele-Health Care

The next questions are about virtual or tele healthcare, meaning health care or medical advice
delivered via phone call, video call, or text message.

76.

Since March 12, 2020 have you avoided accessing virtual or tele healthcare because
you're trans or non-binary?



77.

Yes
No

Since March 12, 2020 have you accessed virtual or tele healthcare?




Yes
No → Skip to #78

77a.

Since March 12, 2020, did you receive virtual or tele healthcare via… (Please

check all that apply)

❑
❑
❑
❑

Phone call
Video call
Text message or other direct messaging service
Other, please specify: __________________________

77b.

❑
❑
❑

What kind of care did you receive virtually? (Please check all that apply)

Physical health care
Mental health care
Other, please specify: _________________________

If your answer to 77b was not “physical health care”, please skip to #78.
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77c.



78.

Did you access this care because you had symptoms of COVID-19?

Yes
No

In general, would you prefer virtual over in-person care when COVID-19 is no longer an

issue?



79.

Yes
No

Can you explain the reasons for your preference?

Primary Care

The next questions are about primary care.

80.

Do you currently have a primary health care provider? By this, we mean one health
professional that you regularly see or talk to when you need care or advice for your
health.






Yes, a family doctor
Yes, a nurse practitioner
No, I receive primary health care at a walk-in clinic → Skip to #83
Not at the present time → Skip to #83

136

81.

Since March 12, 2020 have you seen or spoken to your primary health care provider?




Yes
No → Skip to #82

If you have not had symptoms of COVID-19, please skip to #82.

81a.

Have you seen or spoken to your primary health care provider about your own
symptoms of COVID-19, whether or not you've been diagnosed?



82.

Yes
No

Since March 12, 2020 have you avoided talking to your primary care provider about any
health concerns?






Yes
No → Skip to #83
I have not needed primary care during this time → Skip to #83
My primary care provider is not seeing non-urgent patients during this time →
Skip to #83
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82a.

What were your reasons for avoiding primary care since March 12, 2020? (Please
check all that apply)

❑
❑
❑
❑
❑
❑

Concern about being exposed to COVID-19
My health concern didn’t seem urgent or important enough
Couldn’t bring a support person to appointments
Couldn’t access patient navigator
Concern about how my voice would be perceived over the phone
Other, please specify: _____________________________

Emergency Care

The next questions are about going to the emergency room (ER) for issues concerning your own
health.

83.

Since September 2019, have you avoided going to the emergency room (when you
needed care) because you are trans or non-binary?





Yes
No → Skip to #84
I have not needed emergency care during this time → Skip to #85

83a. Did this happen since March 12, 2020?




84.

Yes
No
I have not needed emergency care during this time → Skip to #86

Since March 12, 2020 have you avoided going to the emergency room (when you needed
care) because you were worried about being exposed to COVID-19?





Yes
No
I have not needed emergency care during this time
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Gender-Affirming Medical Care

In the next questions, we would like to learn about your access to gender-affirming medical care
during the pandemic. For our purposes, “gender-affirming medical care” refers to puberty
blockers, gender-affirming hormones, surgeries, and/or body modifications.

85.

Which of the following applies to your current situation regarding puberty blockers,
hormones and/or surgery? (Please check only one)







I have had the gender-affirming medical treatment that I need/want
I am in the process of completing gender-affirming medical treatment
I am planning to receive gender-affirming medical treatment, but have not begun →
Skip to #87
I am not planning to receive gender-affirming medical treatment → Skip to #89
I am not sure whether I am going to seek gender-affirming medical treatment → Skip
to #89

The next questions are about hormones. When we ask about hormones, this includes puberty
blockers.

86.

Do you take hormones?



86a.




Yes
No → Skip to #87
Right now, do you have access to hormones?
Yes
No
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86b.




Since March 12, 2020, have you had interruptions in taking hormones?
Yes
No → Skip to #87

86c. For what reasons were you unable to access hormones? (Please check all that
apply)

❑
❑
❑
❑
❑
❑
❑
❑

Couldn’t afford it
Couldn’t go to the pharmacy
Couldn’t get my prescription renewed
Couldn’t get syringes or needles
Drug shortages
Nobody to help with injections
People in my household couldn’t know I’m taking hormones
Other, please specify: __________________________________

If you are currently taking hormones (answered yes to #86), please skip to #89.

87.

Since March 12, 2020, have you been unable to get a new prescription or referral for
hormones?





Yes
No → Skip to #88
I haven’t needed this during this time → Skip to #88
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87a.

Did this happen because of restrictions related to COVID-19 (e.g. clinic

closures)?



88.

Yes
No

Before March 12, 2020, did you have an appointment booked to have a gender-affirming
surgery in the future?




Yes
No → Skip to #89

88a. Have you had a surgery appointment canceled or postponed due to the current
COVID-19 outbreak?





Yes
No → Skip to #89
Not yet, but I expect it will → Skip to #89

88b.




Yes
No

88c.

❑
❑
❑
❑
❑
❑
❑

What kind of surgery was cancelled or postponed? (Please check all that apply)

Chest surgery, please specify: ____________________________
Genital gender-affirming surgery, please specify: _________________________
Removal of uterus (hysterectomy) or removal of ovaries (oophorectomy)
Voice surgery
Adam’s apple surgery
Facial surgery
Other, please specify: ________________________________________________

88d.




Was an alternative date set for this surgery?

Have you had this surgery yet?
Yes
No
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89.

Has the current COVID-19 outbreak limited your access to the following aspects of
gender-affirming health care?
89a.





Binders, packers, or gaffs
Yes
No
Not applicable

89b.





Non-medical supplies (e.g. makeup, shaving supplies, wigs)
Yes
No
Not applicable

89c.

Medical material that is important after surgery (e.g. vaginal dilators, chest
compress)





Yes
No
Not applicable

89d.




90.

Post-operative care following gender-affirming surgery
Yes
No
Not applicable

At any point since March 12, 2020, have you needed any of the following services, but
been unable to access them because of the COVID-19 pandemic? (Please check all that
apply)

❑
❑
❑
❑
❑
❑
❑
❑

Dental care
Optometry or ophthalmology
Physical therapy or chiropractic care
Religious or spiritual practice
Activity groups for youth
Child care
Immigration or settlement services
Legal services
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❑
❑

Other, please specify: ________________________________
None of the above

Your Household

Next we’re going to ask some questions about your living arrangements, and household members.
Household members are people you live with, or people who live with you.

91.

What is your legal marital status right now?







92.

On March 12, 2020, what were your living arrangements? (Please check all that apply)







93.

Single, never married
Separated
Divorced
Widowed
Living common-law
Married

Housing you own or rent
Temporarily with someone who pays for housing
Permanently with someone who pays for housing
Shelter, motel, in a car, or other unstable housing
Institutional housing (e.g. long-term care, military housing, prison)
Other, please specify: __________________________________

What are your current living arrangements? (Please check all that apply)








Housing you own or rent
Temporarily with someone who pays for housing
Permanently with someone who pays for housing
Shelter, motel, in a car, or other unstable housing
Institutional housing (e.g. long-term care, military housing, prison)
Other, please specify: __________________________________
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94.

Since March 12, 2020, have your living arrangements changed for reasons related to the
COVID-19 pandemic?



95.

Yes
No

Since March 12, 2020, have your household members changed for reasons related to the
COVID-19 pandemic?




96.

Yes
No

For reasons related to the COVID-19 pandemic, have you lived with a household member
who is unsupportive of your gender?



97.

Yes
No

In general, how supportive of your gender identity or expression are the following
people? These people may or may not be living with you right now.
They
don’t

Not

Very

know

applicable











































Not at

Not

all

very

Somewhat





97b. Your spouse or partner(s)



97c. Your child(ren)
97d. Your grandchild(ren)

97a. Your parent(s) or
guardian(s)
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98.

Excluding members of your household, how many people in total did you come in close
contact with yesterday?
'Close contact' means within 2 meters or 6 feet. Include any people such as co-workers,
relatives, neighbours, delivery workers, other shoppers, health professionals and
restaurant employees.





99.

No contact with people outside my household
1 to 2 individuals
Between 3 to 5 individuals
6 or more individuals

Excluding members of your household, how many people in total did you come in close
contact with during the last 7 days?
'Close contact' means within 2 meters or 6 feet. Include any people such as co-workers,
relatives, neighbours, delivery workers, other shoppers, health professionals and
restaurant employees.






100.

No contact with people outside my household
Between 1 to 3 individuals
Between 4 and 8 individuals
Between 9 and 15 individuals
16 or more individuals

When was the last time you touched another person?






Today → Skip to #101
This week → Skip to #101
This month
Before March 12, 2020

100a.

How much has this lack of human touch bothered you?





A lot
Somewhat
Not at all
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The next questions are about intimate partner violence.
If you need to speak to someone immediately about your mental health, please contact Canada’s
Trans Life Line (call 877-330-6366), the Indigenous Hope for Wellness Help Line (call 1-855242-3310), Crisis Services Canada (call 1-833-456-4566 or text 45645 [call 1-866-277-3553 in
Quebec]), or Kids Help Phone (call 1-800-668-6868 or text CONNECT to 686868).

101.

Since September 2019, has a romantic partner done any of the following towards you?

(Please check all that apply)

❑
❑
❑
❑
❑
❑
102.

Since March 12, 2020, have these behaviours…




103.

Insulted, swore, shouted, or yelled at you
Tried to control who I talked to or where I went
Threatened to hurt you
Pushed, shoved, shook, or pinned you down
Forced or pressured you to engage in a sexual activity when you didn’t want to
None of the above → Skip to #103

Increased
Stayed the same
Decreased

Since September 2019, have you done any of the following towards a romantic partner?
(Please check all that apply)

❑
❑
❑
❑
❑
❑

Insulted, swore, shouted, or yelled at them
Tried to control who they talked to or where they went
Threatened to hurt them
Pushed, shoved, shook, or pinned them down
Forced or pressured the other person to engage in a sexual activity when they didn’t
want to
None of the above → Skip to #105
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104.

Since March 12, 2020, have these behaviours…





Increased
Stayed the same
Decreased

Next we’re going to ask about your experiences finding community and support since
March 12, 2020.

105.

Since March 12, 2020, how often do you feel…
105a.




105b.




105c.




106.

Left out?
Often
Some of the time
Hardly ever
Isolated?
Often
Some of the time
Hardly ever
That you lack companionship?
Often
Some of the time
Hardly ever

Before March 12, 2020, did you have a peer or friend group of other trans and non-binary
people? This could be online or in person.



Yes
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107.

No

Since March 12, 2020, has your access to trans and non-binary peer or friend gatherings
(online or in person)…




108.

Increased
Stayed the same
Decreased

How often is each of the following kinds of support available to you right now?
108a. Someone to help you if you were confined to bed?

None of the time

A little of the time

Some of the time

Most of the time

All of the time











108b. Someone to take you to the doctor if you needed it?
None of the time

A little of the time

Some of the time

Most of the time

All of the time











108c. Someone to have a good time with?
None of the time

A little of the time

Some of the time

Most of the time

All of the time











108d. Someone to prepare your meals if you were unable to do it yourself?
None of the time

A little of the time

Some of the time

Most of the time

All of the time











108e. Someone to help with daily chores if you were sick?

148

None of the time

A little of the time

Some of the time

Most of the time

All of the time











108f. Someone to turn to for suggestions about how to deal with a personal problem?
None of the time

A little of the time

Some of the time

Most of the time

All of the time











108g. Someone who understands your problems?
None of the time

A little of the time

Some of the time

Most of the time

All of the time











108h. Someone to love you and make you feel wanted?
None of the time

A little of the time

Some of the time

Most of the time

All of the time











The next question is about experiences of discrimination related to the COVID-19 pandemic.
If you need to speak to someone immediately about your mental health, please contact Canada’s
Trans Life Line (call 877-330-6366), the Indigenous Hope for Wellness Help Line (call 1-855242-3310), Crisis Services Canada (call 1-833-456-4566 or text 45645 [call 1-866-277-3553 in
Quebec]), or Kids Help Phone (call 1-800-668-6868 or text CONNECT to 686868).
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109.

Since March 12, 2020, have any of the following things happened to you because of
COVID-19? (Please check all that apply)

❑
❑
❑
❑
❑
❑
❑
❑

You were accused of having or spreading COVID-19
You were blamed for the pandemic
You were stopped by police or security over social distancing concerns
Your property was damaged
You experienced verbal threats or harassment
You were assaulted
Other, please specify: _______________________________
None of the above → Skip to #110

109a.

Is there anything you would like us to know about this?

COVID-19 Concerns and Safety
Finally, we have some questions about your concerns during the COVID-19 pandemic, and how
you’re managing to stay safe.

110.

How concerned are you about each of the following impacts of COVID-19?
110a.





My own health
Extremely
Very
Somewhat
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110b.





110c.





110d.





110e.





110f.





110g.

Not at all
Maintaining social ties
Extremely
Very
Somewhat
Not at all
Family stress from confinement
Extremely
Very
Somewhat
Not at all
Violence in your home
Extremely
Very
Somewhat
Not at all
Increased presence of police and security
Extremely
Very
Somewhat
Not at all
Access to hormones or puberty blockers
Extremely
Very
Somewhat
Not at all
Backlog of gender-affirming surgeries
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110h.





111.

Extremely
Very
Somewhat
Not at all
My health care will be deemed non-essential
Extremely
Very
Somewhat
Not at all

Which of the following precautions have you taken to reduce your risk of exposure to
COVID-19? (Please check all that apply)

❑
❑
❑
❑
❑
❑
❑
❑
❑
❑
❑
❑
❑
❑
❑

Stocked up on essentials at a grocery store or pharmacy
Filled prescriptions
Made a plan for caring for household members who are ill
Made a plan for other non-household members (e.g., elderly relatives)
Made a plan for communicating with family, friends and neighbours
Avoided leaving the house for non-essential reasons
Used social distancing when out in public (i.e., made changes in your everyday routine to
minimize close contact with others.)
Avoided crowds and large gathering
Avoided indoor public spaces (e.g. bars or restaurants)
Washed your hands more regularly
Avoided touching your face
Cancelled travel
Worked from home
Other, please specify: _______________________________
None of the above

112.

Which of the following precautions have you wanted to take, but haven’t been able to?

(Please check all that apply)

❑
❑
❑
❑
❑
❑

Stocked up on essentials at a grocery store or pharmacy
Filled prescriptions
Made a plan for caring for household members who are ill
Made a plan for other non-household members (e.g., elderly relatives)
Made a plan for communicating with family, friends and neighbours
Avoided leaving the house for non-essential reasons
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❑
❑
❑
❑
❑
❑
❑
❑
❑

Used social distancing when out in public (i.e., made changes in your everyday routine to
minimize close contact with others.)
Avoided crowds and large gathering
Avoided indoor public spaces (e.g. bars or restaurants)
Washed your hands more regularly
Avoided touching your face
Cancelled travel
Worked from home
Other, please specify: _______________________________
I have been able to take the precautions I wanted to

113.

Can you tell us how the COVID-19 pandemic has impacted you as a trans or non-binary
person, whether positive or negative?
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114.

Can you tell us some things you’ve been doing to take care of yourself during the

COVID-19 pandemic?
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